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Abstract
A SURVEY OF CANNABIS CONSUMPTION AND IMPLICATIONS OF AN
EXPERIMENTAL POLICY MANIPULATION AMONG YOUNG ADULTS
By Alyssa Rudy B.S.
A thesis proposal submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2018.
Major Director: Dr. Caroline Cobb, Assistant Professor, Department of Psychology
The purpose of this online cross-sectional study was to identify cannabis user profiles by
administration method and examine how differential cannabis policies influence intentions
among young adults. Participants were assigned randomly to one of three hypothetical cannabis
policy conditions (recreationally legal; medically legal; illegal). Within conditions, participants
completed measures regarding cannabis use, including administration methods, cannabis
attitudes, norms, perceived behavioral control, self-efficacy, and intentions. Latent class analysis
(LCA) was used to determine sub-groups of past 30-day cannabis users by administration
method followed by sub-group comparisons. Condition effects on intentions and associated
variables were examined using ANCOVA. Four classes (Low-Blunt, Low-Bong, Mod-Poly,
High-Poly) differing in demographics and tobacco use were identified. Recreationally and
medically legal policy conditions resulted in more favorable cannabis attitudes, higher selfefficacy, and higher intentions to use compared to the illegal policy condition. Results inform
cannabis intervention efforts and longitudinal research on the effects of cannabis policy changes.

Introduction
Overview and Motivation
Cannabis, a well-known drug class used for recreational and medicinal purposes, is the
most frequently used illegal drug in the United States (US; Center for Behavioral Health
Statistics and Quality [CBHSQ], 2015). Prevalence trends demonstrate that in the past decade,
past 12-month use of cannabis has increased from 4.1% to 9.5% among US adults (Hasin et al.,
2015). Despite little change in US federal cannabis restrictions, during this same time, state-level
cannabis policies have been evolving rapidly regarding medicinal use as well as recreational use.
The changes in cannabis policy warrant investigation in order to reduce the potential harms of
cannabis legalization. Cannabis policy changes affect the methods in which cannabis is
consumed, patterns of cannabis use, and the types of individuals who consume cannabis
(Borodovsky, Crosier, Lee, Sargent, & Budney, 2016; Hanson, 2016). 1 Differential consumption
methods may be associated with different use patterns, health-related effects, and (e.g.,
demographic) predictors and correlates of cannabis use. Information is needed to address gaps in
knowledge regarding cannabis user profiles by consumption method as well as examine how
differential policy environments may influence cannabis use intentions, particularly among
individuals at high risk for dependence such as young adults.
Cannabis: Cannabinoids, Concentrations, and their Health Effects
The cannabis plant (genus: Cannabis) has several well-characterized strains/species
including Cannabis sativa, Cannabis indica, and Cannabis ruderalis (Sawler et al., 2015). Each

1

Consumption refers to any type of cannabis use including inhalation, eating, and drinking. Ingestion
refers to eating and drinking.
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species contains different cannabinoid contents, and each prompt a variety of subjective effects.
Pure Cannabis sativa elicits subjective cerebral effects while pure Cannabis indica varieties are
well-known for their sedative effects (Sawler et al., 2015). Many varieties that are used for
consumption are sexually propagated hybrids that contain genes from both cannabis sativa and
cannabis indica (Cervantes, 2006; Emboden, 1974). Cannabis ruderalis is not consumed
commonly due to its low levels (approximately 0.2%) of cannabis’ primary psychoactive
cannabinoid, Δ9-tetrahydrocannabinol (THC; Beutler, 1978; Sawler et al., 2015). In all cannabis
species, the flowering tops and leaves, which are harvested typically for consumption, contain
the highest amounts of psychoactive cannabinoids (Adams & Martin, 1996). Cannabinoids, such
as THC, are a class of chemical compounds that are found endogenously (e.g., anandamide) as
well as from exogenous sources such as the cannabis plant that interact with specific cannabinoid
receptors in the brain and other areas of the body (Ameri, 1999).
Cannabinoids, their receptors, and the physiological responses of the interaction between
cannabinoids and cannabinoid receptors are contained in the endocannabinoid system (AizpuruaOlaizola et al., 2016; Mechoulam & Parker, 2013). The cannabis plant contains over 400
chemical constituents of which over 109 are cannabinoids that interact with primarily two
cannabinoid receptors: CB1 and CB2 receptors (El-Alfy et al., 2010; Mehmedic et al., 2010).
Cannabinoid receptors are located in the central and peripheral nervous system of the body. CB1
receptors are mainly concentrated in the brain while CB2 receptors are located primarily in
immune cells. Most research has focused on three cannabinoids in the cannabis plant: THC
(primary psychoactive chemical), cannabinol (CBN; psychoactive but less powerful than THC),
and cannabidiol (CBD; not psychoactive but has other therapeutic properties; Sharma, Murthy, &
2

Bharath, 2012). When extracted, THC is a volatile viscous oil that is highly lipophilic and can be
detected in plasma within seconds after inhalation (via combusted cannabis; Grotenhermen,
2003; Sharma et al., 2012). Oral administration of cannabis results in a slower delivery of THC
as well as time to peak plasma concentration (Grotenhermen, 2003). The lipophilic nature of
THC is related to the distribution pattern within the body resulting in concentration in the brain
and vascularized tissues (Grotenhermen, 2003). Metabolism rates vary dependent on the pattern
of use, dose, and biological measure (e.g., plasma, urine), but urine assays can detect THC
metabolites for up to 12 days following use (Law, Mason, Moffat, Gleadle, & King, 1984).
Cannabis consumption (mediated primarily by the cannabinoids consumed) affects the
brain, body, and behavior in a variety of ways. Dose and route of administration are important to
consider when examining effects associated with cannabis consumption. Some acute effects such
as delusions, hallucinations, and depersonalization are observed typically at only high doses but
are generally short lasting (Advokat, 2014). Recent reports of THC concentration in seized dried
cannabis has increased from 3% in the 1980s to about 12% in 2014 (ElSohly et al., 2016;
Volkow, Baler, Compton, & Weiss, 2014). In contrast, THC concentration for cannabis
concentrates is between 60% and 80% (Stogner & Miller, 2015b). These differences in
concentration may influence associated patterns of cannabis use and related health effects.
Acutely, cannabis use induces feelings of euphoria and relaxation and can result in
impaired memory, decreased performance in cognitive tasks, decreased reaction time, and
negative mood-type effects including panic and paranoia (Ameri, 1999; Sharma et al., 2012).
The pleasurable and rewarding effects of cannabis, particularly THC, are linked primarily to the
widespread use and abuse of this substance (Ameri, 1999; Cooper & Haney, 2009). Like other
3

drugs of abuse, THC activates the mesolimbic dopamine system, a brain area critical for
reinforcing drug-taking behavior (Tanda, Pontieri, & Di Chiara, 1997). Other negative health
effects of cannabis use include suppression of antibody production in the immune system,
increased heart rate, and hypotension (Ameri, 1999; Franz & Frishman, 2016; Rieder, Chauhan,
Singh, Nagarkatti, & Nagarkatti, 2010). Initiation of cannabis use among adolescents and young
adults can also affect the developing brain resulting in impaired neuronal connectivity (Zalesky
et al., 2012), particularly in the prefrontal cortex (Filbey & Yezhuvath, 2013; Gogtay et al.,
2004).
Importantly, in addition to the effects associated with abuse potential and negative health
consequences, cannabinoids also are associated with medically relevant and therapeutic health
effects. Cannabis consumption can produce analgesic, antiemetic, and anticonvulsive effects
(Ameri, 1999; Holland et al., 2006). Prior research suggests that cannabis consumption is
beneficial for cancer patients who experience nausea and other negative side effects from
chemotherapy treatments (Carlini & Cunha, 1981; Holland et al., 2006; Rivera-Olmos & ParraBernal, 2016; Schrot & Hubbard, 2016). Studies show that CBD helps combat Alzheimer’s
disease (Karl, Garner, & Cheng, 2016), multiple sclerosis (Patti et al., 2016), and epilepsy
(Ameri, 1999; Leo, Russo, & Elia, 2016; Lippiello et al., 2016). This diverse range of positive
and negative effects and the risks to younger populations who may initiate cannabis use creates
challenges for cannabis policy and regulation as well as research efforts in this area.
In recent years, the availability of new recreational cannabis forms (i.e., concentrates) and
consumption methods (i.e., electronic heating systems/vaporizers and concentrate/dab rigs) have
increased with little data available concerning their relative health effects. Historically, cannabis
4

has either been consumed by combustion (i.e., smoked) or taken orally (often by mixing with
food; Adams & Martin, 1996; Sharma et al., 2012). As described above, average THC
concentration varies between dried leaves versus concentrates, and THC dose is vital to
understanding the acute effects experienced. In one clinical demonstration, dried cannabis plants
and synthetic THC preparations (controlling for THC concentration) that were either smoked or
ingested orally (via brownies) produced similar dose-dependent effects and subjective effects
when compared between products (i.e., dried cannabis vs. synthetic THC). Unfortunately, these
results were not examined by consumption method (i.e., smoked THC vs. oral THC ingestion;
Wachtel, ElSohly, Ross, Ambre, & de Wit, 2002). More research is needed on the differential
health effects of cannabis forms (e.g., dried vs. concentrate) and methods of cannabis
administration.
Most of the data available only have examined effects of dried and combusted cannabis.
Similar to the health effects observed for combusted tobacco use, combusted cannabis use is
associated with increased coughing and mucus, increased risk of lung disease, exposure to
carbon monoxide, and the potential to develop lung cancer (Martinasek, McGrogan, &
Maysonet, 2016; Yayan & Rasche, 2016). Other forms of cannabis use may elicit unique health
effects. For example, oral cannabis consumption and/or cannabis chewing may not result in
combustion-related side effects but instead produce mouth irritation and other adverse changes to
the oral epithelium (Cho, Hirsch, & Johnstone, 2005). Data from an internet sample of cannabis
users indicated an association between cannabis use via vaporizer (electronic heating system)
and fewer respiratory symptoms controlling for a host of associated factors relative to cannabis
users who did not use a vaporizer (Earleywine & Barnwell, 2007). The current literature on
5

effects of cannabis concentrates is small; however, preliminary studies suggest that use of
cannabis concentrates contributes to a higher incidence of fainting, potential for higher cannabis
withdrawal symptoms due to elevated THC content, potential dangers from consumption of
products made with butane, and an increased risk of psychosis (Di Forti et al., 2015; Loflin &
Earleywine, 2014; Miller, Stogner, & Miller, 2016; Stogner & Miller, 2015a). Taken together,
these data support better assessment of cannabis use in terms of dose and consumption method to
better understand the health implications of these use patterns. These data also indicate that there
may be differential health effects between methods of cannabis administration; therefore, use
patterns of these methods must be further explored.
Trends in Cannabis Use, Abuse, and Dependence
In concert with or potentially in response to evolving cannabis preparations and
consumption methods, current (past 30-day) cannabis use among people over 12 years old has
increased from 14.5 million in 2007 to 22.2 million in 2014 (CBHSQ, 2015). Among those aged
14 to 17 years in 2013, cannabis was the most highly used drug (NIDA, 2015). For young adults
(aged 18-25), past month cannabis use was 20.8% in 2016, which is a 4.9 percentage point rise
from 2004 (CBHSQ, 2015, 2017). Among US adults at large, past month cannabis use was 7.2%
in 2016, an increase of almost 3.1 percentage points since 2002 (CBHSQ, 2017). Specifically, in
Virginia, past 30-day cannabis use among 18-25 year olds was 17.8% in 2016, which is lower
than national prevalence rates for this age group (See Table 1). Among adults aged 26 or older in
Virginia, past 30-day cannabis use was also lower than nationwide rates in 2016. However, these
nationwide and Virginian trends suggest that overall cannabis use in multiple age groups is
increasing at a moderate rate.
6

Table 1. Nationwide and Virginian Prevalence Estimates of Cannabis Use by Age
Nationwide estimates
Past year cannabis
Past 30-day
use
cannabis use

Virginia estimates
Past year cannabis
Past 30-day
use
cannabis use

Youth
Aged 12-17

12.0%

6.5%

11.4%

5.4%

Young adults
Aged 18-25

33.0%

20.8%

30.1%

17.8%

Adults
Aged 26+

11.0%

7.2%

8.5%

6.7%

Note: Virginian estimates from the 2015 NSDUH (CBHSQ, 2016). Nationwide estimates from
the 2016 NSDUH (CBHSQ, 2017).
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As defined by the American Psychiatric Association (APA) Diagnostic and Statistical
Manual for Mental Disorders, fifth edition (DSM-5), cannabis substance use disorder is
classified by the presence of two or more criteria occurring within a 12-month period (APA,
2013). Many of the nationally representative monitoring systems have not transitioned to this
current definition and instead utilize substance use dependence and abuse classification
guidelines from the Diagnostic Statistical Manual for Mental Disorders, fourth edition (DSMIV). Similarities and discrepancies between these categorizations are displayed in Table 2. As is
apparent, the newer cannabis use disorder definition incorporates all of the previous cannabis
dependence use criterion and the majority of the abuse criterion with one addition, the presence
of craving or strong urges to use the substance (BehaveNet, 2016).
Due to the recent changes in diagnostic criterion, the available data collapses cannabis
use and abuse categories in order to identify the prevalence of cannabis use disorder. Although
current cannabis use has increased, the prevalence of cannabis use disorders among those aged
12 and older has decreased from 1.8% in 2002 to 1.6% in 2014 (CBHSQ, 2015). For young
adults (aged 18-25), cannabis use disorder decreased from 6.0% in 2004 to 4.9% in 2014
(CBHSQ, 2015). Among US adults, cannabis use disorder slightly increased from 0.8% in 2002
to 0.9% in 2014 (CBHSQ, 2015). Taken together, national data across multiple groups suggest
that overall cannabis use is increasing moderately while the prevalence of cannabis use disorders
has experienced little change over the same time period. These discrepancies in cannabis use and
disorder incidence may be due to changes in substance disorder criteria as well as lagged effects
in disorder development. Continued surveillance is essential to better understand these trends.
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Table 2. Comparison of Substance Use Disorder, Substance Use Dependence, and Abuse Criterion by DSM Edition
DSM-5 (APA, 2013)
Cannabis use disorder
A problematic pattern of cannabis use leading to clinically
significant impairment or distress, as manifested by at least
two of the following, occurring within a 12-month period:

DSM-IV-TR (BehaveNet, 2016)
Substance (marijuana) use dependence
A maladaptive pattern of substance use, leading to clinically
significant impairment or distress, as manifested by three (or more)
of the following, occurring at any time in the same 12-month period:

Tolerance, as defined by either of the following:
- A need for markedly increased amounts of cannabis to
achieve intoxication or desired effect.
- Markedly diminished effect with continued use of the same
amount of cannabis.
Withdrawal, as manifested by either of the following:
-The characteristic withdrawal syndrome for cannabis.
-Cannabis (or a closely related substance) is taken to relieve or
avoid withdrawal symptoms.
A great deal of time is spent in activities necessary to obtain
cannabis, use cannabis, or recover from its effects.
There is a persistent desire or unsuccessful efforts to cut down
or control cannabis use.
Cannabis is often taken in larger amounts or over a longer
period than was intended.
Continued cannabis use despite having persistent or recurrent
social or interpersonal problems caused or exacerbated by the
effects of cannabis.
Important social, occupational, or recreational activities are
given up/reduced because of cannabis use.
Recurrent cannabis use in situations in which it is physically
hazardous.
Cannabis use is continued despite knowledge of having a
persistent or recurrent physical or psychological problem that
is likely to have been caused or exacerbated by cannabis.
Recurrent cannabis use resulting in a failure to fulfill major
role obligations at work, school, or home.
NA

Tolerance, as defined by either of the following:
- a need for markedly increased amounts of the substance to
achieve intoxication or desired effect
- markedly diminished effect with continued use of the same amount
of the substance
Withdrawal, as manifested by either of the following:
- the characteristic withdrawal syndrome for the substance
- the same (or a closely related) substance is taken to relieve or avoid
withdrawal symptoms
A great deal of time is spent in activities necessary to obtain the
substance, use the substance, or recover from its effects
There is a persistent desire or unsuccessful efforts to cut down or
control substance use
The substance is often taken in larger amounts or over a longer
period than was intended
The substance use is continued despite knowledge of having a
persistent or recurrent physical or psychological problem that is
likely to have been caused or exacerbated by the substance
Important social, occupational, or recreational activities are given up
or reduced because of substance use
NA

Craving, or a strong desire or urge to use cannabis.

NA

NA

NA
NA

DSM-IV-TR (BehaveNet, 2016)
Substance (marijuana) abuse
A maladaptive pattern of substance use leading to
clinically significant impairment or distress, as
manifested by one (or more) of the following,
occurring within a 12-month period
NA

NA

NA
NA
NA
NA

NA
Recurrent substance use in situations in which it is
physically hazardous
Continued substance use despite having persistent or
recurrent social or interpersonal problems caused or
exacerbated by the effects of the substance
Recurrent substance use resulting in a failure to fulfill
major role obligations at work, school, or home.
Recurrent substance-related legal problems (e.g.,
arrests for substance-related disorderly conduct)
NA

Note: NA indicates non-applicable meaning there is no equivalent criteria within this edition
9

Alternative Cannabis Consumption and Production Methods
Most national assessments (e.g., National Survey on Drug Use and Health [NSDUH],
Monitoring the Future [MTF], & Youth Risk Behavior Survey [YRBS]) typically evaluate
cannabis use with broad questions which capture lifetime use, current use (e.g., past month), and
age of initiation. Unfortunately, these general use questions do not capture the wide array of
administration methods or forms available. Forms of cannabis include dried (i.e., cannabis in its
original form), concentrates (e.g., butane hash oil, kief, shatter, wax, and rosin), and cooked
cannabis (which includes tinctures, sprays, and cannabutter, for example). Concentrates,
commonly known as dabs, kief, (butane) hash oil, wax, budder, and shatter, are products with
elevated THC levels compared to traditional dried cannabis (Loflin & Earleywine, 2014; Raber,
Elzinga, & Kaplan, 2015).
Forms of cannabis can be consumed alone or in combination via a variety of methods of
administration. Methods of cannabis administration include smoking or inhaling with joints
(cannabis wrapped in a cigarette rolling paper; often but not always containing tobacco) and
blunts (cannabis wrapped in tobacco leaves or hollowed cigars; often but not always containing
tobacco) as well as use of bowls/pipes, bongs, hot knives, rigs, vaporizers, and edibles (Schauer,
King, Bunnell, Promoff, & McAfee, 2016). Bowls and pipes are devices most often made of
glass and made in a variety of shapes and sizes (see Figure 1A). Cannabis is placed in the
concave “head” of the bowl/pipe where it is combusted by a lighter or other heat source. Bongs
are devices made from glass, plastic or other materials that are composed of a concave orifice
(typically removable) where cannabis is placed and heated but with the addition of a bowl at the
bottom of the device where water is placed (similar to hookah/waterpipe devices; see Figure 1A;
10

Kelly, 2005). Hot knives are commonly used with concentrated cannabis. Two metal knives are
heated with a blowtorch or a kitchen stove and a small amount of cannabis concentrate is placed
on the heated knife blades (Urbanremo, 2015). The cannabis is then inhaled in one of two ways:
1) the knives are situated near the user’s mouth and the user inhales or 2) the knives are placed
under a water bottle with a cut bottom and the user inhales through the top of the water bottle.
Rigs are devices similar to bongs in which a glass, ceramic, or titanium rod (called a “nail”) is
heated with a blowtorch or an electronic heating source (see Figure 2; Raber et al., 2015). Rigs
are used exclusively with cannabis concentrates which immediately aerosolize upon contact with
the nail, and the emissions are inhaled through the top of the device, similar to a bong (Loflin &
Earleywine, 2014; Miller et al., 2016; Raber et al., 2015). Vaporizers are relatively modern
electronic devices commonly known as electronic cigarettes (e-cigarettes) or e-hookahs (Figure
1B; Breland et al., 2016). More commonly, these devices are used with nicotine-containing
liquid (Breland et al., 2016); however, many devices are also manufactured specifically for use
with dried cannabis flowers, cannabis concentrates, or cannabis containing liquid/oil (e.g. Pax,
Atmos vaporizers, Quick draw; Figure 1B; D. C. Lee, Crosier, Borodovsky, Sargent, & Budney,
2016). These devices contain a power source (battery), heating element, or atomizer that, when
activated, warms to a temperature that produces an aerosol to be inhaled (Breland et al., 2016;
Giroud et al., 2015; D. C. Lee et al., 2016). Another method of cannabis consumption is
ingestion of foods or drinks made with cannabis, commonly called “edibles” (Vandrey et al.,
2015). Tinctures are ingestible mixtures of cannabis and high-proof alcohol. The medical
cannabis community commonly use tinctures, mixing them with food, drinks, or placing small
doses directly into their mouths (Schnelle, Grotenhermen, Reif, & Gorter, 1999).
11

Figure 1. Devices for cannabis consumption. Panel A displays typical glass devices including a
bong, rig, and bowl/pipe. Panel B displays electronic devices including a dry material vaporizer
and an electronic cigarette where cannabis-containing liquid would be loaded.
12

Figure 2. A cannabis concentrate rig. A cannabis concentrate rig typically includes a dome
(which helps contain the cannabis emissions) and a nail (where the concentrate preparation is
placed).
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Methods of cannabis production and product development have matured with the passing
of medical and recreational cannabis laws. Traditionally, cannabis grows outdoors in soil;
however, other forms of production such as indoor hydroponics are used to increase yields and
decrease production time (Knight et al., 2010). Hydroponics is a method of growing cannabis,
which does not use soil, but instead uses nutrient-rich water to grow plants. According to
informal reports, indoor growing systems provide the most control over the growing
environment with the use of LED or high-intensity discharge lights, exhaust fans, and
temperature, humidity, and carbon dioxide regulation (Danko, 2016). After cultivation, the dried
cannabis is kept in its original form or made into different forms such as concentrates and
edibles. Growing cannabis often involves propagation and crossbreeding in order to create new
species of cannabis (Beutler, 1978). Due to the legalitiy of cannabis, the rapid growth of the
cannabis industry, and the development of new production technologies, the regulation and
monitoring of cannabis production is extremely difficult.
Limited research exists on the prevalence of specific methods or combinations of
methods of cannabis consumption, but combustion-based methods appear to be the most
commonly used by recreational cannabis users (Hindocha, Freeman, Ferris, Lynskey, &
Winstock, 2016; J. R. Hughes et al., 2014; Schauer, King, et al., 2016). Baseline data from a
study of US adult daily cannabis users during 2010-2012 showed that more than half reported
weekly usual use of joints (53%), blunts (51%), pipes (55%), or bongs (32%) with fewer
individuals endorsing use of vaporizers (6%; J. R. Hughes et al., 2014). Within this same study,
participants’ daily use of cannabis, including consumption method, was monitored using an
interactive voice response system; these data indicated that over 3 months, 59% used at least
14

three modes of cannabis consumption (joint, blunt, and pipe/bong/vaporizer) and fewer than 3%
used only joints or only blunts. Pipe/bong use was the most prevalent method endorsed during
daily monitoring (49% of days monitored) followed by blunts (33%) and joints (16%; J. R.
Hughes et al., 2014). A more recent nationally representative sample of US adults collected in
2014 indicated that among past 30-day users, the most common methods of use were pipe/bowl
(50%), joint (49%), bong/water pipe/hookah (22%), and blunt/cigar (20%) with fewer
individuals endorsing use of edibles (16%), vaporizer/electronic devices (8%), and cannabis in
“other ways” (5%; Schauer, King, et al., 2016). Most users endorsed one method of use (59%)
but almost 20% endorsed three or more; importantly results from this study did not distinguish
which methods were most commonly used exclusively or in combination (Schauer, King, et al.,
2016).
An online global (Europe, Australasia, and US/Americas) survey performed in 2013
including over 70,000 participants examined past year cannabis use characteristics by route of
administration focusing specifically on those consumed in combination with tobacco (i.e., joint
with tobacco, pipe with tobacco) versus those without tobacco (i.e., joint without tobacco, pipe
without tobacco, vaporizer; Hindocha et al., 2016). Overall results indicated tobacco-containing
administration methods (i.e., joints with tobacco) were endorsed more highly (66%) by past year
users, but the most common non-tobacco-containing method was pipe without tobacco (12%).
US-specific results revealed an alternative pattern with non-tobacco methods emerging as the
most common (92%) with the highest endorsement for pipe without tobacco (48%; Hindocha et
al., 2016). Taken together, these data support the assertion that combustion-based methods are
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likely the most common among US cannabis users, but importantly new trends, policies, and
available methods of use are likely to influence these patterns of consumption.
Inhalation and oral methods of administration may be increasing in some populations.
The Association for Cannabis and Medicine (Cologne, Germany) administered an anonymous
survey in Germany, Austria, and Switzerland in 1999 to examine use patterns of self-medicating
cannabis users (Schnelle et al., 1999). Across their lifetime, almost half of the sample (49%) had
used inhalation methods of administration, 14% had used oral methods, and 37% had used both
inhalation and oral methods (Schnelle et al., 1999). The same researchers administered the
survey again in 2001 in Germany and Switzerland (Grotenhermen & Schnelle, 2003). Over half
of participants (56%) inhaled cannabis products while 17% consumed cannabis orally and 23%
used both inhalation and oral methods (Grotenhermen & Schnelle, 2003). These results indicate
that, in certain populations, the individual use of inhalation and oral methods of cannabis
administration may have increased over time while the dual use of oral and inhalation methods
decreased.
The use of cannabis concentrates via rig or vaporizer specifically appears to be one of the
newest consumption methods to gain popularity and is coupled with concerning reports of abuserelated side effects associated with use. A Google Trends analysis between 2004-2015 which
tracked the frequency of searches that included “dabbing” (i.e., concentrate use) and other
similar terms indicated that prior to 2013 cannabis smoking and edible terms were searched more
often than “dabbing” (Zhang, Zheng, Zeng, & Leischow, 2016). However, by 2015, “dabbing”
searches were 28% higher than cannabis smoking terms and 58% higher than edible search terms
(Zhang et al., 2016). An online US study conducted in 2014 included 357 adults who had used
16

concentrates in their lifetime (Loflin & Earleywine, 2014). Results showed that approximately
one third (32%) of participants who had tried a vaporizer with concentrates preferred using a
vaporizer instead of a hash oil rig. Data also indicated that the most endorsed reasons for using
concentrates were that participants needed fewer doses to receive the same effect, the “high” was
stronger, and the “high” felt subjectively different (Loflin & Earleywine, 2014). This data serves
as an indication of the rapidly growing popularity of cannabis concentrates.
Vaporizer use in particular appears to be prevalent in US adolescent and young adult
populations. Among a 2014 sample of US high school students in Connecticut, 5% had ever used
cannabis with a vaporizer (Morean, Kong, Camenga, Cavallo, & Krishnan-Sarin, 2015). When
restricted to ever cannabis users, 18% had used cannabis with a vaporizer. The study also
measured the type of cannabis product used in vaporizers (i.e., concentrates or dried cannabis).
Among those who indicated lifetime cannabis use, 16% had used concentrates in a vaporizer
while 23% had used dried cannabis in a vaporizer (Morean et al., 2015). Among a 2013 sample
of US high school students in Colorado (assessed prior to implementation of retail marijuana
availability), 20% reported past 30-day cannabis use with 85% of users indicating smoking as
their usual mode of consumption followed by vaporizing (6%), edibles (5%), and other (4%; R.
M. Johnson et al., 2016). Among one sample of US undergraduate students in Arizona, past year
cannabis use was reported by 44%, with cannabis vaping at 23%, and over half of past-year
cannabis users had tried cannabis vaping in the past year (51%; Jones, Hill, Pardini, & Meier,
2016).
Importantly, vaporizer use for cannabis consumption is not limited to younger age
groups. In an online sample of cannabis-using US adults in 2014-2015, 61% of the sample had
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ever used a vaporizer to administer cannabis, with most indicating using a vaping pen (45%) or
tabletop device (23%) followed by a portable device (15%) and e-cigarette (11%; D. C. Lee et
al., 2016). Dual use of smoking and vaping cannabis was reported by 76% of the sample;
smoking cannabis was still the most frequently used method and very few individuals reported
vaping exclusively (D. C. Lee et al., 2016). An online study conducted in 2013 included 96
adults who used a vaporizer with cannabis (Malouff, Rooke, & Copeland, 2013). The most
endorsed reasons for using cannabis with a vaporizer were perceived health benefits, better taste,
no smoke smell/discreetness, and users achieve more drug effects with the same amount of
cannabis (Malouff et al., 2013)
As presented above, patterns of cannabis consumption in the US are evolving, and while
combustion-based methods still may be the most common, engagement in multiple methods is
also prevalent. Differential consumption methods may be associated with varying use
trajectories, patterns of consumption, psychoactive and health-related effects, and importantly,
predictors and correlates of cannabis use. Of the latter, predictors and correlates may be most
useful for informing the development of prevention or intervention efforts to reduce the negative
consequences associated with cannabis use.
Predictors and Correlates of Cannabis Use
Available data suggests that a wide range of factors are predictive of cannabis use
including demographics (i.e., race/ethnicity, gender), harm perceptions regarding cannabis use,
and other risk-taking behaviors such as tobacco and alcohol use. Importantly, much of the work
regarding predictive factors of cannabis use includes populations/settings outside of the US so
consideration of the population studied is key when interpreting findings (Haug, Nunez, Becker,
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Gmel, & Schaub, 2014; Korhonen et al., 2010; McGee, Williams, Poulton, & Moffitt, 2000;
Mills, Kisely, Alati, Strathearn, & Najman, 2016). Patterns of predictive factors may differ in
US populations relative to other international settings due to the differences in cannabis policy
environments.
In terms of demographics, the literature on race/ethnicity correlates among cannabis users
is heterogeneous. Among one sample of young adults, identifying as American Indian/Alaskan
Native was positively associated with past year cannabis use (R. M. Johnson et al., 2015);
however, other evidence suggested that cannabis users are more likely to identify as White (Bell,
Wechsler, & Johnston, 1997; R. M. Johnson et al., 2016; Kaynak et al., 2013) or Asian (R. M.
Johnson et al., 2016). For gender, the literature is more consistent with cannabis use being
strongly associated with identifying as a male (Bell et al., 1997; Coffey, Lynskey, Wolfe, &
Patton, 2000; R. M. Johnson et al., 2016; D. C. Lee et al., 2016). More recent work suggests that
demographic correlates may differ based on method of cannabis use. In one examination, bluntonly users were more likely to be African American compared to non-blunt cannabis users (A.
Cohn, Johnson, Ehlke, & Villanti, 2016). Men are also more likely to use cannabis with a
vaporizer (Jones et al., 2016; D. C. Lee et al., 2016; Morean et al., 2015) which is consistent with
data from tobacco literature regarding electronic cigarette use (McMillen, Gottlieb, Shaefer,
Winickoff, & Klein, 2015; Schoenborn & Gindi, 2015). These data support inquiry into
understanding the demographic profiles of cannabis users by consumption method endorsed.
Harm perceptions regarding cannabis is another class of factors that has strong
associations with use. Among a nationally representative sample of US adults in 2012 and 2014,
approximately 29% perceived a great risk of harm from monthly cannabis use (A. Hughes,
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Lipari, & Williams, 2016). Areas of the country with highest levels of use were more likely to
perceive lower risks of harm from monthly cannabis use (A. Hughes et al., 2016). Among a
sample of 725 US young adults in 2007, non-cannabis users reported higher risk of future
academic consequences compared to cannabis users (71% vs. 20%; Kilmer, Hunt, Lee, &
Neighbors, 2007). In the same study, non-cannabis users also perceived higher risk of social
consequences compared to cannabis users (55% vs. 9%; Kilmer et al., 2007). Among a sample of
young adults in Australia in 2006, lifetime cannabis users perceived cannabis as less risky
compared to participants who had never used cannabis (O'Callaghan, Reid, & Copeland, 2006).
Lifetime cannabis users’ perceived risk was lower on six dimensions: feeling sick after using,
using other drugs, having accidents while under the influence of cannabis, legal consequences,
physical health, and dependence problems (O'Callaghan et al., 2006). These data indicate that
perceptions of lower health, social, and academic risks of cannabis use are associated with
cannabis use.
A range of other risky behaviors are also associated with cannabis use. Early initiation of
cigarette smoking (at age 12 or earlier) is highly predictive of subsequent cannabis use during
adolescence (Korhonen et al., 2010). Tobacco and alcohol use also predict cannabis use and
dependence in young adulthood (Coffey et al., 2000; Mills et al., 2016). Alcohol, nicotine, and
cannabis dependence at age 18 are predictors of past-year cannabis use among young adults
(Haug et al., 2014; McGee et al., 2000). Cannabis use is also associated with other illicit drug use
(Secades-Villa, Garcia-Rodriguez, Jin, Wang, & Blanco, 2015). A study using the DomainSpecific Risk-Taking scale found that young adult cannabis users were more likely to exhibit
social (e.g., disagreeing with a friend), health/safety (e.g., engaging in unprotected sex), and
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ethical risks (e.g., stealing) compared to non-cannabis users (Gilman, Calderon, Curran, & Evins,
2015). Indices of high impulsivity/sensation seeking also are predictive of past year cannabis use
and cannabis dependence in young adulthood (Haug et al., 2014; Kaynak et al., 2013; McGee et
al., 2000). As indicated, engagement in other risky behaviors including alcohol and tobacco use,
along with certain race/ethnicity, gender, and harm perception profiles are predictive of general
cannabis use. Further, some literature indicates there are differential patterns of predictors and
correlates depending on methods of cannabis use.
Few studies have investigated predictors or correlates of alternative forms of cannabis
consumption such as vaporizer, concentrate, edible, and blunt use. Among those available,
predictors of vaporizer use are cannabis initiation at a young age (D. C. Lee et al., 2016), more
frequent (daily) cannabis use (D. C. Lee et al., 2016), high socioeconomic status (Jones et al.,
2016), higher perceived health (D. C. Lee et al., 2016), lifetime cigarette use (Morean et al.,
2015), and using a vaporizer for nicotine products (Jones et al., 2016; D. C. Lee et al., 2016).
Among one large online sample of cannabis users in the US, ever cannabis vaporizer users
indicated positive perceptions of vaping cannabis in terms of “health,” “taste,” “high,” and
“satisfaction” (D. C. Lee et al., 2016). One qualitative study published in 2016 showed that
among US youth aged 15-17, users who preferred edibles were more likely to endorse concerns
about smoking cannabis (Friese, Slater, Annechino, & Battle, 2016). Interestingly, edible users in
this sample also cited specific risks associated with edible use including edible-induced deaths,
risks of the intense edible “high,” and unclear strength/content of edible products. This same
study suggested that edible use was perceived as more prevalent among females and more
accepted by females due to lack of smell or lower risk of discovery by adults (Friese et al.,
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2016). One study examined correlates of blunt use and non-blunt cannabis use among US adults
using data from the 2013 NSDUH (A. Cohn et al., 2016). Results indicated blunt users and nonblunt cannabis users had similar associations (more likely to be Black, young, male, and used
other substances in the past month; however, non-blunt cannabis users had weaker associations
with these variables than blunt users.
Predictors and correlates of endorsing multiple consumption cannabis methods (i.e., polyuse) or particular patterns of cannabis use (i.e., vaporizers and rigs or vaporizers-only) have not
been examined extensively in the literature. This lack of knowledge in combination with rapidly
changing device types and technology all challenge the categorization and understanding of
cannabis users and patterns of use. Importantly, there are statistical techniques that are optimized
for identifying latent sub-groups of populations, which may be best suited for addressing this
challenge.
Methods to Understand Patterns and Correlates of Cannabis Consumption: Latent Class
Analysis
Among many statistical techniques used to understand drug-taking behavior, latent class
analysis (LCA) has emerged as an advantageous person-centered approach to classify patterns of
substance use (Evans-Polce, Lanza, & Maggs, 2016; Haardorfer et al., 2016; Harrell, Naqvi,
Plunk, Ji, & Martins, 2016; Nasim, Blank, Cobb, & Eissenberg, 2012; Nasim et al., 2016; Tzilos,
Reddy, Caviness, Anderson, & Stein, 2016). LCA groups individuals into “latent” (i.e.,
unobserved) classes based on their patterns of responding on indicator variables (i.e., selected
variables relevant to the research question of interest; McCutcheon, 1987). LCA has been used
among adolescent (Harrell et al., 2016; Nasim et al., 2012) and young adult populations (Evans22

Polce et al., 2016; Haardorfer et al., 2016; Nasim et al., 2016; Tzilos et al., 2016) to understand
patterns of tobacco use, cannabis/alcohol, as well as other illicit substances (Haardorfer et al.,
2016). One advantage is the use of LCA in combination with more traditional regression
analyses to examine correlates of class membership. This combination of statistical techniques
allows for the exploration of the differential characteristics of sub-groups identified (Pearson,
Bravo, Conner, & Marijuana Outcomes Study, 2017).
LCA can be used to examine latent patterns of substance use behavior among specific
drug classes such as tobacco products. A national sample of US adolescent cigarette smokers
was categorized using indicator variables that included measures of cigarette smoking frequency
and intensity, lifetime smoking status, smoking persistence, and past 30-day alternative tobacco
use (smokeless tobacco, cigars, bidi, clove cigarettes; Nasim et al., 2012). Each of the six latent
classes predicted by the model (class membership prevalence ranged from 55-33%) was defined
by unique patterns of cigarette and alternative tobacco product use: Class 1 (non-daily, light
smokers), Class 2 (light smokers), Class 3 (light smokers who use alternative tobacco products),
Class 4 (intermittent smokers), Class 5 (daily smokers), and Class 6 (daily smokers who use
alternative tobacco products). Multinomial regression was used to examine demographic and
other smoking-related covariates (i.e., nicotine dependence) that differed between classes.
Findings suggested that smokers who engaged in alternative tobacco product use (Classes 3 and
6) exhibited higher nicotine dependence symptomology, consistent with a greater risk profile.
These data highlighted the variability in tobacco product consumption among youth and the
importance of alternative tobacco product assessment and inclusion in tobacco prevention
interventions.
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LCA has also been used to understand latent poly-substance use patterns. In a large
regional sample of US college students, indicators were selected to capture tobacco use
prevalence (frequency of past 4-month and past 30-day use for cigarettes, little cigars/cigarillos,
smokeless tobacco, e-cigarettes, and hookah), cannabis use, and alcohol use (Haardorfer et al.,
2016). Two sets of LCA models were developed to divide individuals into classes based on their
substance use over the past 4 months and past 30 days. Both LCA models resulted in five distinct
classes with differing class membership rates: Class 1 (abstainers), Class 2 (alcohol-only), Class
3 (light poly-tobacco users), Class 4 (heavy poly-tobacco users), and Class 5 (little
cigar/cigarillo-hookah-marijuana co-users; Haardorfer et al., 2016). Multinomial regression
analyses were used to identify demographic, perception-related, and social factor correlates that
differed by class membership. Findings revealed important variations in these associations (e.g.,
light poly-tobacco users were more likely to have parents that used tobacco but less likely to
have friends who used tobacco) that were informative for prevention efforts.
LCA may be particularly useful for identifying sub-groups of cannabis users that differ
by cannabis use behaviors. Available data indicate that cannabis users, as a whole, have lower
harm perceptions (A. Hughes et al., 2016; Kilmer et al., 2007; O'Callaghan et al., 2006) and
exhibit risky behaviors (Badiani et al., 2015; Gilman et al., 2015; Secades-Villa et al., 2015) but
also are characterized by heterogeneous use patterns (Hindocha et al., 2016; Loflin &
Earleywine, 2014; Schauer, King, et al., 2016). Therefore, there may be sub-groups within the
larger population of cannabis users which may be best elucidated using LCA techniques.
Considering the rapid evolution of cannabis consumption methods and US state-level polices
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regarding medicinal and recreational use, this information gap will be critical to assess in terms
of understanding the changing population of cannabis users in the US.
History of Cannabis Policy in the US
Like many drugs, cannabis and policy regarding its use has experienced dramatic shifts in
political and public opinion since its introduction to modern society. The first record of cannabis
use was for medicinal purposes by the ancient Chinese in 2700 BC (M. A. Lee, 2012).
Originally, cannabis was used in medicinal teas as a remedy for a variety of ailments including
gout, malaria, and constipation. In the 1800s, cannabis was still widely used to treat ailments (M.
A. Lee, 2012). By the late 1800’s oral ingestion methods were widely switched to smoking
(combustion-based; M. A. Lee, 2012). By the 1930s, 24 US states had banned cannabis.
In 1937, the first US law that indirectly banned the production, possession, and usage of
cannabis, The Marihuana Tax Act, was passed and created a soaring tax on cannabis (M. A. Lee,
2012). By this time, cannabis use had decreased for medicinal purposes and been replaced with
modern-age medicines like aspirin. However, recreational cannabis use still continued (M. A.
Lee, 2012). In the 1950s, the US federal government prioritized the restriction of drug use with
the Boggs Amendment in 1951 and the Narcotics Control Act of 1956, which both increased
penalties for violating drug laws including those regarding cannabis.
In 1970, the Marihuana Tax Act of 1937 was deemed unconstitutional and was replaced
by the Controlled Substances Act (CSA; M. A. Lee, 2012). The CSA, initially passed in 1970,
was intended by the US Congress to further regulate cannabis and other substances by addressing
multiple points including the manufacture, possession, and distribution of substances (FDA,
2009). Since 1970, nine amendments to the CSA have been passed to further regulate other drugs
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of abuse (e.g., steroids and psychotropic drugs), chemical precursors, and structurally similar
drugs (FDA, 2009). The CSA also created a five-tiered classification system to rank the
“potential for abuse” for each substance. According to the CSA, Schedule I substances have a
high potential for abuse, no medical uses, and are not safe to use under medical supervision,
while Schedule V substances have a low potential for abuse. The classification system
categorizes natural cannabis as a Schedule I drug in the US; although synthetic forms of THC
(i.e., dronabinol) are classified as Schedule III. The federal penalty for a first offense with
possession of cannabis is a fine no less than $1,000 and up to 1 year in prison (Yeh, 2015).
However, these penalties vary by state. States with decriminalized laws have minor penalties
while other states with strict cannabis laws have major penalties (up to the federal level).
Although cannabis remains illegal on a federal level, many states have opted to create
new laws regarding cannabis. In 1996, California was the first state to legalize cannabis for
medicinal purposes (Hanson, 2016). During the next twenty years, 28 more states and
Washington, DC followed California’s lead to legalize cannabis medicinally (Hanson, 2016).
Although medicinal cannabis laws between states are heterogeneous; generally, the laws legally
constitute the possession of a certain amount of cannabis and the cultivation of a specific number
of plants only if the consumer has a medical condition that allows for the use of cannabis (see
Table 3 for a summary by state). In 2012, Colorado became the first state to legalize both
recreational and medicinal cannabis, followed by Washington one month later. Both Oregon and
Alaska legalized cannabis for recreational and medicinal purposes in 2014. In 2016, California,
Maine, Massachusetts, and Nevada legalized recreational cannabis (NPR, 2016). Recreational
cannabis laws vary across states by possession amount, number of plants allowed for cultivation,
26

Table 3. US States with Legalized Medical and/or Recreational Cannabis Laws
US State

Cannabis products
available for
recreational use

Recreational use policy details
(Ballotpedia, 2016; NORML, 2016)

Alaska
Arizona
Arkansas
California

Cannabis
products
available for
medical use
Yes
Yes
Yes
Yes

Yes
No
No
Yes

Colorado

Yes

Yes

Connecticut
Delaware
Washington, DC
Florida
Hawaii
Illinois
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Montana
Nevada

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

No
No
Yes
No
No
No
No
Yes
No
Yes
No
No
No
Yes

New Hampshire
New Jersey
New Mexico
New York
North Dakota
Ohio
Oregon

Yes
Yes
Yes
Yes
Yes
Yes
Yes

No
No
No
No
No
No
Yes

Pennsylvania
Rhode Island
Vermont
Washington

Yes
Yes
Yes
Yes

No
No
No
Yes

1 oz. possession & grow 6 plants
--1 oz. possession, grow 6 plants, & 8
g concentrate possession
1 oz. possession, grow 6 plants, & 1
oz. concentrates
--2 oz. possession & grow 6 plants
----2.5 oz. possession & grow 6 plants
-1 oz. possession & grow 6 plants
---1 oz. possession, grow 6 plants, &
1/8th oz. concentrates
------1 oz. possession, grow 4 plants, 72
oz. of liquid concentrates, 16 oz. of
solid concentrates, & 1 oz. of
concentrate extract
---1 oz possession, 72 oz. of liquid
concentrates, 16 oz. of solid
concentrates, & 7 g of concentrate
extract.

Note. Cannabis products include dried plant material.
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and the legality of concentrates; however, all recreational cannabis users must be 21 years of age
(see Table 3). Importantly, although many states and territories have relatively ignored the
stipulations of the CSA, cannabis is still considered federally illegal in the US. These changes in
cannabis policy warrant investigation in order to reduce the potential harms of cannabis
legalization on youth and young adults (Choo & Emery, 2016; Dirisu, Shickle, & Elsey, 2016).
Methods to Evaluate Cannabis Policy Change
Measures of trends in drug use are among the most common means to measure the effects
of policy changes. One study, conducted between 1991 and 2001, paired states with and without
medical cannabis laws and compared past month adolescent cannabis use rates (Choo et al.,
2014). No significant differences were found in adolescent cannabis use between states with and
without medical cannabis laws (Choo et al., 2014). However, another more recent study
conducted between 2002 and 2011 using data from NSDUH determined that adolescent cannabis
use rose after the implementation of medical cannabis laws (Stolzenberg, D'Alessio, & Dariano,
2016). Results from another study that examined the effects of international drug policies in a
sample of over 170,0000 adolescents in 38 countries across three time points (2001-2010)
determined that adolescents were more likely to report lifetime, past year, and regular cannabis
use in legalized policy environments relative to an illegalized policy environment (Shi, Lenzi, &
An, 2015). A study using longitudinal data in 1991-2011 from the YRBS examined the influence
of medical cannabis laws on cannabis use among adolescents (J. Johnson, Hodgkin, & Harris,
2017). After controlling for state, year, and demographic variables, data indicated that although
cannabis use was higher in states with medical cannabis laws, there was no increase in past 3028

day cannabis use or past 30-day heavy cannabis use due to policy changes in states with medical
cannabis laws (J. Johnson et al., 2017). Therefore, researchers indicated that the difference in
cannabis use patterns was likely due to differential social norms in each state, not medical
cannabis laws (J. Johnson et al., 2017). These data illustrate the utility of prospectively
monitoring changes in drug use before and after a policy is implemented as well as collecting
other measures (i.e., social norm indices) that may be associated with changes in drug use.
There is strong evidence that effects of drug policy on drug use behavior may be
influenced by harm perceptions and social norms (L. D. Johnston, O'Malley, Miech, Bachman, &
Schulenberg, 2016). The MTF study examines 12th graders’ perceived risk, disapproval, and
availability of cannabis as well as cannabis use behavior over time (L. D. Johnston et al., 2016).
Between the 1970s and 1990s, perceived risk of cannabis decreased while cannabis use increased
(L. D. Johnston et al., 2016). This trend suggests that increasing perceived risk may reduce rates
of cannabis use, but more recent data highlights the complex interplay of these factors. From
2005 to 2015, the percentage of 12th graders who reported a “great risk” in regular cannabis use
declined from 58% to 32% without a corresponding increase in cannabis use (L. D. Johnston et
al., 2016). Other data from the NSDUH indicated that the relationship between harm perceptions
and cannabis use patterns among people aged 12 and older (i.e., lower perceived harm coupled
with lower use) was still evident from 2012 to 2014 (A. Hughes et al., 2016). This decline in
perceived risk among both youth and adult populations could be the result of cannabis policy
changes throughout the US. Cannabis was prohibited originally in the US due to its purported
increased harm potential to users. Due to the relaxation of medical and recreational cannabis
laws, youth now may interpret that cannabis is safe to use (Dirisu et al., 2016). Data from the
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MTF study also indicated that although personal disapproval of regular cannabis use in 2015
remained high for 12th graders (71%), this rate of disapproval had decreased since 2007 (83%).
In addition, the percentage of 12th graders who reported that cannabis is “fairly easy” or “very
easy” to obtain has remained between 80% and 90% since the beginning of the MTF study in
1975. In 2015, approximately 80% of 12th graders reported that cannabis was easily attainable.
Decreases in perceived risk and disapproval of cannabis use and increases in access to cannabis
in response to cannabis policy changes could contribute to future changes in cannabis use
patterns (L. D. Johnston et al., 2016).
Although useful, measuring drug use patterns and associated factors like harm
perceptions and disapproval before and after a policy change is not always viable (such as the
case of a future or proposed policy change). In addition, pre-post designs cannot be used to
examine unintended effects prior to policy implementation or when developing cannabis policies
that have not been implemented in other environments. For example, pre-post studies do not
illustrate what effects would occur following legalization of cannabis in a state with longstanding restrictions on medical and recreational use (e.g., Virginia or Wisconsin). While these
environments may share some similarities to other US states where cannabis legalization policy
has been implemented (e.g., Colorado or Washington), important geographical and population
differences may result in differential outcomes and risks to certain populations like youth or
young adults.
Simulation modeling provides one option to help predict the impact of future or
hypothetical health policies, but this approach typically requires longitudinal data sources as
a foundation (Cobb et al., 2015; Levy, Bauer, & Lee, 2006; Levy et al., 2011). Choice
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experiments, which are primarily used in economics literature, could also be used to evaluate
potential policy changes; however, these methods incorporate a price or “willingness to pay”
framework which would add a price dynamic into the study. Prices for cannabis tend to fluctuate
depending on the state, the specific laws in that state or locality, and the time of year. Choice
experiments would add a price confound into the methods (Barnes et al., 2013; Ginon, Chabanet,
Combris, & Issanchou, 2014; Olesen, Alfnes, Bensze Røra, & Kolstad, 2010). Importantly, the
use of experimental and cross-sectional designs, often driven by behavior change theories, can
provide an additional alternative to understand the impact of potential policy changes related to
health behaviors (Darmon, Lacroix, Muller, & Ruffieux, 2014; Epstein et al., 2015; Pesko,
Kenkel, Wang, & Hughes, 2016; Wackowski, Manderski, & Delnevo, 2014). These types of
studies typically compare alterations of a policy environment relative to the "status quo" or
current policy environment to determine the hypothetical impact on outcomes of interest
including intentions to use a drug (e.g.., tobacco, cannabis) or engage in a behavior (e.g.,
purchase food/calories). Many studies have shown a consistent relationship between intentions to
use cannabis and the actual use of cannabis (D'Amico, Miles, & Tucker, 2015; L. D. Johnston et
al., 2016; Kilmer et al., 2007; Lopez-Quintero & Neumark, 2010). Using intentions as a primary
outcome is supported by several theories of behavior change including the Theory of Planned
Behavior (Ajzen, 1991).
As described above, methods to evaluate cannabis policy change are dominated by longterm longitudinal approaches that measure cannabis use behavior and proximal outcomes such as
cannabis harm perceptions, disapproval rates, and availability perceptions. In the absence of such
data or to address questions regarding the potential effects of new or hypothetical cannabis
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policy in untested environments, alternative methods must be considered. Experimental designs
using a behavior change theory approach provide one such option.
Predicting cannabis use: The Theory of Planned Behavior. The Theory of Planned
Behavior (TPB) is a suitable framework for assessing cannabis use and the antecedents of use
(Ajzen, 1991; Conner & McMillan, 1999). The TPB reveals motivations and beliefs about a
behavior (Glanz, 2015). The TPB incorporates three main factors that influence intentions to act
on a behavior and consequently, the behavior itself (Ajzen, 1991). The three factors that
influence intentions are 1) attitudes about the behavior, 2) subjective norms, and 3) perceived
behavioral control. Attitudes are positive or negative beliefs about a behavior. Subjective norms
are the perceived pressures to perform a behavior. Two distinct categories fall under subjective
norms: injunctive/normative and descriptive norms. Injunctive norms are the pressures one feels
from others to engage in a behavior (i.e., “do others think you should use cannabis?”).
Descriptive norms are perceived beliefs about the engagement of others in the behavior (i.e., “do
you think other people use cannabis?”). Perceived behavioral control is how easy or difficult it is
for one to perform the behavior. Self-efficacy is the belief one has in their ability to complete a
behavior. These three components – attitudes, subjective norms, and perceived behavioral
control – contribute to intentions to perform a behavior. Ajzen postulated that intentions to
perform a behavior is the closest antecedent to actual behavior performance (1991). A
hypothetical cannabis policy environment may influence attitudes, subjective norms, and
perceived behavioral control, as well as intentions to perform a behavior.
Due to the hypothetical nature of evaluating changes in a not-yet implemented cannabis
policy environment, it is challenging to measure actual behavior performed. Therefore,
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examining intentions to perform a behavior, in this case, intention to use cannabis, as well as
associated influential factors (attitudes, subjective norms, and perceived behavioral control)
provide the optimal tools in which to test the impact of a future cannabis policy change within an
existing policy environment.
Statement of the Problem
Cannabis is a drug class that can be used in a variety of ways through different types of
administration with little data available regarding patterns and profiles of cannabis use by
consumption method. This information may have important implications for understanding
cannabis user populations and informing cannabis prevention and intervention efforts. The US
cannabis policy environment is rapidly changing with many states legalizing cannabis for
medicinal use and several states legalizing recreational cannabis despite the US federal
government’s illegal stance on cannabis. These changes may affect the methods in which
cannabis is consumed and the types of individuals who consume cannabis. Understanding the
influence of cannabis policy changes (i.e., increased legalization) is needed particularly for
unique and untested environments that may respond differentially compared to those where
cannabis policy has already been implemented and/or longitudinal data is available. Assessment
of these policy-related outcomes using an experimentally-based design can inform regulators and
potentially limit the harms of future cannabis policy on at-risk populations such as young adults.
The Present Study
This study has three primary aims: 1) to assess what methods and patterns of cannabis
consumption are most prevalent among young adults using an LCA approach, 2) to test whether
certain patterns of cannabis use are associated with differential demographics, harm perceptions,
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and risk taking behaviors, and 3) to determine if hypothetical cannabis policy environments
(legal-policy vs. medical-policy vs. illegal-policy) influence attitudes, injunctive norms,
perceived behavioral control, and intentions to use cannabis among a young adult population.
Hypothesis 1: The largest latent classes of young adult cannabis users will involve
combustion-based methods of cannabis use (i.e., joints, blunts, bongs, and bowls). Evidence
from adolescent populations indicates combusted methods are most prevalent (D. C. Lee et al.,
2016). We expect that users may engage in multiple methods of cannabis consumption, but
combustion-based consumption or a combination of combustion-based methods will be most
frequent.
Hypothesis 2: Latent classes composed of primarily combusted cannabis users will
significantly differ in their demographics, harm perceptions, and risk-taking behaviors from user
classes who primarily use non-combusted forms of cannabis. Combusted cannabis users will
more likely be male, White/Caucasian, have lower harm perceptions about cannabis, and have
greater risk-taking behaviors relative to those who use non-combusted forms of cannabis.
Hypothesis 3: The legal-policy condition will elicit the highest intentions to use,
followed by the medical-policy condition and the illegal-policy condition. Self-reported attitudes
towards cannabis will be highest (i.e., more favorable) in the legal-policy condition and lowest in
the illegal-policy condition. Injunctive norms regarding cannabis will be highest in the legalpolicy condition followed by the medical-policy condition and the illegal-policy condition.
Measures of perceived behavioral control and self-efficacy to use cannabis will be highest in the
legal-policy condition and lowest in the illegal-policy condition.
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Method
Selection of Participants
Approximately 1,500 students from a large (30,000 students) urban university in a MidAtlantic US city were potentially eligible to participate in this online cross-sectional survey study
based on course enrollment. Eligibility criteria to participate were undergraduate student status,
at least 18 years of age, and enrolled in a course where research credit could be earned to satisfy
course requirements. Between February 2017 and May 2017, 543 participants enrolled in this
study. Of the total participants enrolled, 86 were excluded from analyses due to failure to meet
inclusion criteria (n = 3), failing to complete any of the survey beyond consent (n = 24), failing
the attention check (n = 18), failing to finish the survey in its entirety (n = 40), and illogical
responding (n = 1). The final sample consisted of 457 participants of which 208 (45.5%) met
criteria for analysis for Hypothesis 1 (past month cannabis use), 204 (45.5%) met criteria for
analysis for Hypothesis 2, and 446 (97.6%) met criteria for analysis for Hypothesis 3.
The enrolled sample met the proposed sample projection of approximately 500
participants which was based on preliminary data from two similarly designed studies of
undergraduate students at the same institution performed in Spring 2016 and Fall 2016. These
two previous studies estimated past 30-day cannabis use was between 30-50% (personal
communication with C. Cobb) resulting in an analytic sample for the LCA (Hypothesis 1)
between 150-250 individuals (meeting minimum sample size for LCA which ranges from 100500; Collins & Wugalter, 1992; Finch & Bronk, 2011; Wurpts & Geiser, 2014). The projected
sample size for the LCA was expected to at least allow for logistic regression analyses to
examine differences in demographics, harm perceptions, and risk behaviors between the two
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largest classes identified. For Hypothesis 3, the entire sample (N ≈ 500) was planned to be
utilized, and a power analysis aimed to detect a small to medium effect size of f = 0.25 (α = 0.05,
with at least 6 covariates; power = 0.95) for an analysis of covariance (ANCOVA) determined a
minimum sample size of 210 participants (GPower 3.1.9.2). The current study protocol and all
associated measures were approved by the Virginia Commonwealth University’s Institutional
Review Board.
Procedures
The study design was cross-sectional and used only self-report measures, which was
executed completely online. Interested individuals reviewed study information via an online
study system developed specifically for administering undergraduate research studies (SONA,
https://vcu.sona-systems.com). If interested in a particular study, participants “signed up” to gain
access to the study-specific weblink. After clicking on the weblink, participants were routed
outside of the study system to a secure webpage that hosted the experimental survey
(administered via Qualtrics). After reviewing a brief description of the study and expected
involvement, participants clicked yes to agree to continue and then confirmed eligibility status
(age ≥18 years old and undergraduate student status). Participants who did not meet eligibility
requirements were excluded from participation. Following eligibility confirmation, the survey
consisted of baseline measures asked of all participants (see Measures below) followed by
randomization to one of three hypothetical cannabis policy conditions: legal-policy, medicalpolicy, or illegal-policy (see Cannabis Policy Conditions below). At the conclusion of the
survey, participants were directed to click a weblink which directed them to a separate survey
webpage to leave their name and contact information for crediting purposes (0.5 credits per
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person). This practice ensured the survey data were not directly linked with individuals’
identifying information. Individuals who did not reach this point in the survey were instructed to
email the survey administrators directly to obtain partial credit (0.20 credits).
Measures
All participants completed a survey that consisted of baseline demographic measures,
cannabis, alcohol, and tobacco use patterns, tobacco and cannabis harm perceptions, risk-taking
behaviors, and baseline intentions to use cannabis followed by randomization to one of three
hypothetical cannabis policy conditions (legal-policy, medical-policy, or illegal-policy) where
cannabis attitudes, descriptive norms, injunctive norms, perceived behavioral control, selfefficacy, and intentions to use were assessed. One question was included as an attention check,
and participants who completed an answer to the attention check were excluded from analysis (n
= 18).
Cannabis Policy Conditions. After completing baseline measures, participants were
randomly assigned automatically to one of three hypothetical cannabis policy conditions (legalpolicy, medical-policy, or illegal-policy) where a condition-specific scenario was presented (See
Table 4 and Appendix A). Participants were instructed to complete six measures within the
context of the assigned hypothetical cannabis policy condition (i.e., attitudes, descriptive norms,
injunctive norms, perceived behavioral control, self-efficacy, and behavioral intentions). In order
to ensure participants recalled which policy condition to which they were randomized, a policy
condition prompt was shown at the top of each measure (See Appendix B).
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Table 4. Cannabis Policy Conditions
Item
Description

Legal Cannabis
Policy Condition

US State Policy
Reference
(Ballotpedia,
2016; NORML,
2016)
NA

Medical Cannabis
Policy Condition

US State Policy
Reference

Illegal Cannabis
Policy Condition

Instructions

The next several
sections will ask
you to answer the
questions in the
context of the
situation stated
below. Imagine
you live in a state
where marijuana
is medically and
recreationally
LEGAL.

Medical use

Age

The next several
sections will ask
you to answer the
questions in the
context of the
situation stated
below. Imagine
you live in a state
where marijuana
is medically
LEGAL

NA

The next several
sections will ask
you to answer the
questions in the
context of the
situation stated
below. Imagine
you live in a state
where marijuana
is medically and
recreationally
ILLEGAL.

Patients with
written medical
consent may
possess up to two
ounces of medical
marijuana.

Similar to
Colorado,
Washington, DC,
New Hampshire,
New Jersey, &
Vermont

NA

NA

Marijuana in any
form may not be
prescribed by any
medical
professional.

All illegal
cannabis states

Use of marijuana
is legal for anyone
over the age of 21.

All recreational
cannabis laws

Anyone with
written medical
consent may use
marijuana for
medical purposes.

Similar to
Arizona, Illinois,
& Maine

Use of marijuana
is illegal for
anyone of any
age.

All illegal
cannabis states
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US State Policy
Reference
(Ballotpedia,
2016; NORML,
2016)
NA

Possession
and
cultivation

Anyone over the
age of 21 may
possess up to 1
ounce of retail
marijuana and
may grow up to 6
marijuana plants.

Similar to Alaska,
California, &
Colorado

Purchase

Purchase of up to
one ounce of retail
marijuana at a
marijuana
dispensary is legal
for anyone 21
years or older.

Similar to Alaska,
California,
Colorado, &
Oregon

Anyone with
written medical
consent may
possess up to 2.5
ounces of medical
marijuana.
Growing
marijuana of any
amount may result
in criminal
prosecution and
fines.
Anyone with
written medical
consent may
purchase up to 2.5
ounces of
marijuana for
medical purposes
at a dispensary.
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Similar to
Arizona, Illinois,
& Maine

Possession and
growing of
marijuana of any
amount results in
criminal
prosecution and
fines.

All illegal
cannabis states

Similar to
Arizona, Illinois,
& Maine

Purchase of
marijuana of any
amount and from
any source results
in criminal
prosecution and
fines.

All illegal
cannabis states

Measures Administered Prior to Randomization.
Demographic Measures. Participants were asked to provide demographic information on
age, gender, race/ethnicity, school level, year in college, grades in school, and current and past
state of residency prior to college (Youth Risk Behavior Survey Questionnaire, 2015). Gender
categories included “man,” “woman,” and “other,” which was recoded to exclude “other”
categories from all analyses due to low frequencies. Race/ethnicity categories included “White or
European-American,” “Black, Afro-Caribbean, or African American,” “Asian American,”
“American Indian or Alaska Native,” “Native Hawaiian or Other Pacific Islander,” “Middle
Eastern or Arab American,” “Multiracial,” or “Other.” Participants were also asked “Do you
consider yourself Hispanic/Latino(a)?” with response options “Yes” and “No.” If a respondent
indicated that they considered themselves to be Hispanic/Latino, they were classified as only
Hispanic/Latino, and this variable was collapsed into the race/ethnicity variable. Race/ethnicity
was recoded to “White,” “Black,” “Asian,” “Hispanic/Latino,” and “Multiracial/Other” due to
low frequencies. School level included the following categories: “high school graduate,” “GED
or equivalent,” “some college/no degree,” “associate degree,” “bachelor’s degree,” “master’s
degree,” and “professional or doctoral degree.” School level was recoded to “high school or
GED,” “some college/no degree,” and “associate’s or bachelor’s degree” due to low frequencies.
Year in college categories included “first year,” “second year,” “third year,” “fourth year,” and
“fifth or more year.” School grades categories included “Mostly A’s,” “Mostly B’s,” “Mostly
C’s,” “Mostly D’s,” “Mostly F’s,” “None of these grades,” and “Not Sure.” School grades were
recoded to “Mostly A’s,” “Mostly B’s,” “Mostly C’s, D’s or F’s,” and “Not sure.” For these
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analyses, respondents who reported “Not sure” for school grades were excluded. For current and
past state of residency, a drop-down list of US states was provided.
Cannabis Use Patterns. Lifetime (yes/no), past 12-month (number of days), past 30-day
(number of days), and past 30-day occasions (number of occasions) of cannabis were determined
by adapting questions from the MTF questionnaire (L. Johnston, Miech, O'Malley, Bachman, &
Schulenberg, 2015) and the NSDUH (CBHSQ, 2015). Among lifetime cannabis users, age of
cannabis initiation, cannabis prescription status (yes/no), and methods of lifetime use were
assessed; however, age of cannabis initiation was not used for analyses and will not be discussed
further. Methods of cannabis administration used in their lifetime were determined by listing the
following methods: “joint or spliff (marijuana cigarette with or without tobacco)” [joint], “blunt
(cigar with marijuana with or without tobacco)” [blunt], “bowl or pipe that does not include
water (glass of homemade pipe/apple pipe)” [bowl/pipe], “bong or water pipe (bucket/gravity)”
[bong], “hot knife,” “rig (typically used with concentrates and a blowtorch or electric heat
source)” [rig], “Vaporizer or other electronic device (Volcano or PAX) [vaporizer],” “edibles
(brownies, teas, tinctures, sprays)” [edible], or “some other way.” Lifetime use of types of
cannabis were determined by the following options: “dried marijuana (bud, weed),” “butane hash
oil (BHO), kief, shatter, wax, rosin, or another form of concentrate,” “cooked (tincture, spray,
cannabutter),” or “some other way.” Lifetime methods of cannabis administration and lifetime
use of types of cannabis were not used for analyses and will not be discussed further. Only users
who reported using cannabis at least once in the past 12 months were asked about past 30-day
use. Among past 30-day users, occasions and days of cannabis administration methods and
cannabis types used were assessed (using same list of methods and types above). The frequency
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of administration method and cannabis type used (number of occasions for each method and type
endorsed) also was measured. Types of cannabis used in the past 30 days were not used in
analyses; therefore, will not be discussed further. The past 30-day occasion frequency of joint,
blunt, bowl/pipe, bong, and edible were recoded where 0 = 0 occasions, 1 = 1-10 occasions, and
2 = 10 or more occasions. Past 30-day occasion frequency of vaporizer and rig were combined
and recoded into a dichotomous item where 0 = 0 occasions and 1 = 1 or more occasions. The
amount of cannabis used in the past 30 days (“Do you know how much marijuana you have used
(in ounces) during the last month?”) was assessed; response options: “None,” “less than ½
ounce,” “about ½ ounce,” “about 1 ounce,” “about 2 ounces,” “3 to 5 ounces,” “6 or more
ounces,” “6 or more ounces,” and include “Don’t know.” Current state of cannabis intoxication
(yes/no) during the survey administration was assessed (Davis et al., 2014; Schauer, King, et al.,
2016) of all lifetime cannabis users. Preferred type of cannabis and preferred method of cannabis
administration were also assessed. Amount of cannabis used in the past 30 days, current state of
cannabis intoxication, preferred type of cannabis, and preferred method of cannabis
administration were not included in analyses; therefore, they will not be discussed further.
Cannabis Dependence. Cannabis dependence was assessed using the Severity of
Dependence Scale for cannabis users (van der Pol et al., 2013). The scale contains five items that
determine the degree of cannabis dependence. All five items started with the same stem “During
the past year…” The first four items were “… did you think your use of marijuana was out of
control?” “…did the prospect of missing a dose of marijuana make you anxious or worried?”
“…did you worry about your use of marijuana?” and “…did you wish you could stop the use of
marijuana?” For the first four items, response options included “never/almost never (1),”
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“sometimes (2),” “often (3),” and “always/nearly always (4).” The fifth item was “…how
difficult did you find it to stop, or go without marijuana?” with response options as “not difficult
(1),” “quite difficult (2),” “very difficult (3),” and “impossible (4).” Responses were totaled with
a maximum score of 15.
Alcohol Use Patterns. Lifetime (yes/no) alcohol use was determined by adapting
questions from the NSDUH (CBHSQ, 2015). The item asked, “Have you ever, even once, had a
drink of any type of alcoholic beverage?”
Tobacco Use Patterns and Tobacco Dependence. Lifetime and 30-day use (number of
days) of tobacco products were included “Cigarettes,” “Traditional cigars (Macanudo, Romeo y
Julieta, or Arturo Fuente),” “Pipe (with tobacco),” “Little cigars/cigarillos (like Black & Milds,
Swisher Sweets, or Phillies Blunt),” “E-cigarettes (like BLU or NJOY),” “Chewing tobacco (like
Levi Garrett, Red Man, or Beech Nut),” “Dip/snuff (like Skoal or Copenhagen),” “Snus (like
Camel Snus),” “Dissolvable tobacco products (like Ariva, Stonewall, Camel Orbs, Sticks or
Strips),” “Hookah/shisha (hookah tobacco),” and “Nicotine replacement products (like gum,
patches, lozenges)” (A. M. Cohn, Johnson, Rath, & Villanti, 2016; Rath et al., 2016). Past 30day tobacco use by product was dichotomized to “yes” or “no.” The first type of tobacco product
ever used and the age of tobacco initiation were assessed, but were not used in the current
analyses, as well as lifetime tobacco use; therefore, these variables will not be discussed further.
Fagerström Test for Nicotine Dependence was also assessed, but was not used for the current
analyses and will not be discussed further (Heatherton, Kozlowski, Frecker, & Fagerstrom,
1991).
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Baseline Cannabis Behavioral Intention. This scale, adapted from the marijuana
behavioral intention scale (Armitage, Armitage, Conner, Loach, & Willetts, 1999), consists of
three items: “I intend to use cannabis/marijuana,” “I plan to use cannabis/marijuana,” and “I
want to use cannabis/marijuana.” Responses range from (1) “Definitely do not” to (7) “Definitely
do” (α = 0.98). Responses were totaled, and the maximum score was 21.
Harm Perceptions. Harm perceptions were determined by asking “How harmful do you
think that the following products are to your health?” (α = 0.94). Responses ranged from (1)
“Extremely harmful” to (7) “Not harmful at all” and included (8) “Don’t know.” Harm
perceptions were determined for the following items: “tobacco cigarettes,” “smokeless tobacco,”
“electronic cigarettes,” “hookah/shisha,” “little cigars/cigarillos,” “marijuana used in a joint or
spliff,” “marijuana used in a blunt,” “marijuana used in a bowl or pipe that does not include
water,” “marijuana used in a bong or waterpipe,” “marijuana used with a hot knife,” “marijuana
used with a rig,” “marijuana used with a vaporizer or other electronic device,” and “marijuana in
an edible form.” Tobacco-product harm perceptions were not used in the current analysis;
therefore, they were excluded. Cannabis-product harm perceptions were averaged across
cannabis products assessed excluding “marijuana used with a hot knife” and “marijuana used
with a rig” due to a high proportion of cases that responded “don’t know.” Cases that responded
“don’t know” to any cannabis harm perception item were also excluded.
Brief Sensation Seeking Scale. Sensation seeking was measured with the Brief Sensation
Seeking Scale (BSSS; α = 0.75; Hoyle, 2002). This scale contains eight items and measures the
amount to which one agrees or disagrees with engaging in risky activities (e.g., “I like to do
frightening things” and “I would like to try bungee jumping”). Responses range from (1)
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“Strongly disagree” to (5) “Strongly agree.” The scale was recoded by averaging scores across
items (Hoyle, 2002).
Measures Administered Post-Randomization.
Attitudes. Attitudes in the framework of the TPB are beliefs about a behavior. Attitudes
also capture the degree to which a person positively or negatively values a behavior (α = 0.97;
(Glanz, 2015). Attitudes about cannabis use were measured using an adapted 7-point bipolar
scale (Armitage et al., 1999). The scale includes four items, which begin with the same stem
“My using cannabis would be…” Responses range from (1) “bad, unfavorable, negative,
unsatisfactory” to (7) “good, favorable, positive, satisfactory” and were totaled for a maximum
score of 28.
Descriptive Norms. Descriptive norms are perceptions about others’ behavioral patterns
(α = 0.74; (Glanz, 2015). For the present study, two adapted items were used for measuring
perceptions of prevalence of cannabis use (e.g. “Most people my age have tried
cannabis/marijuana,” “Most people my age smoke cannabis/marijuana regularly”; (Ito, Henry,
Cordova, & Bryan, 2015). Responses range from (1) “Strongly disagree” to (7) “Strongly agree.”
Descriptive norms were not used in data analysis.
Injunctive Norms. Injunctive norms are one’s perceptions of whether peers and other
important people approve of the behavior. Injunctive norms were measured with three adapted
items (α = 0.77; e.g. “My friends think I should use cannabis/marijuana,” “My parents think I
should use cannabis/marijuana,” “People who are important to me think I should use
cannabis/marijuana”; Ito et al., 2015). Responses range from (1) “Strongly disagree” to (7)
“Strongly agree” and were totaled for a maximum score of 21.
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Attention Check. In order to avoid satisficing among participants, an attention check was
included (e.g., “If you read this question, please leave the answer blank”). Responses range from
(1) “Strongly disagree” to (7) “Strongly agree.” Participants who responded to this question were
excluded from analyses (n = 18).
Perceived Behavioral Control. Perceived behavioral control is the amount of self-control
one has over a behavior. Perceived behavioral control was measured with three items (α = 0.69;
e.g., “Whether or not I use cannabis/marijuana is entirely up to me,” “How much personal
control do you feel you have over using cannabis/marijuana?,” “How much do you feel that
using cannabis/marijuana is beyond your control?”; Armitage et al., 1999). Responses range
from (1) “Strongly agree, very little control, very much so” to (7) “Strongly disagree, complete
control, not at all.” Responses were totaled for a maximum score of 21.
Self-Efficacy. Although similar to perceived behavioral control, self-efficacy is the
perceived ability one has to perform a behavior. The self-efficacy measure consisted of four
items: “I believe I would have the ability to use cannabis/marijuana” “To what extent do you see
yourself as being capable of using cannabis/marijuana?” “How confident are you that you would
be able to use cannabis/marijuana?” “If it were entirely up to me, I am confident that I would be
able to use cannabis/marijuana” (α = 0.95; Armitage et al., 1999). Responses range from (1)
“Definitely do not, very incapable of using cannabis/marijuana, very unsure, strongly disagree”
to (7) “Definitely do, very capable of using cannabis/marijuana, very sure, strongly agree.
Responses were totaled for a maximum score of 28.
Post-Randomization Behavioral Intention. This scale, adapted from the marijuana
behavioral intention scale (α = 0.98; (Armitage et al., 1999), consisted of three items: “I intend to
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use cannabis/marijuana,” “I plan to use cannabis/marijuana,” and “I want to use
cannabis/marijuana.” Responses range from (1) “Definitely do not” to (7) “Definitely do.”
Responses were totaled, and the maximum score was 21.
Data Analysis
Following data cleaning and recoding procedures described above, statistical analyses
were conducted using IBM SPSS (Version 22), STATA (StataCorp, 2015), and Latent Gold 4.5
(Statistical Innovations Inc., 2008). Overall sample descriptives were performed on the included
sample as well as bivariate comparisons for demographic items between those that were
excluded from primary analyses.
Hypothesis 1 was analyzed using LCA with Latent Gold 4.5. First, individuals who
endorsed using cannabis on at least one occasion in the past 30 days were selected (n = 208).
Latent class indicator variables included frequency of past-month occasions used for six methods
of cannabis consumption assessed: joint, blunt, bowl/pipe, bong, edible, and vaporizer/rig.
Responses for vaporizer and rig use were combined due to low frequencies. The item assessing
hot knife use was excluded from this analysis due to low use frequencies (n = 1) and the item
assessing cannabis use “some other way” was recoded by hand wherein each item was assessed
and combined with other methods of administration categories. An exploratory strategy was used
to build the model, increasing the number of classes until a class solution that adequately fit the
data was determined. Ten latent class models were estimated to identify underlying groups of
cannabis users based on methods of cannabis administration. The Bayesian Information Criterion
(BIC) and the Akaike Information Criterion (AIC) were used as global fit indices as well as
consideration of parsimony (fewest number of parameters; Npar) and low likelihood of
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classification error to determine the appropriate number of latent classes in the model (EvansPolce et al., 2016; Haardorfer et al., 2016; Nasim et al., 2016; Tzilos et al., 2016). The L2 statistic
was also used to determine model fit. The L2 statistic specifies the associations that are
unexplained in the model with lower L2 values indicating a better model fit. Additionally, in
order to test more precisely for model fit, bootstrapping was used. Bootstrapping accounts for
violations of the assumption that the L2 statistic has a chi square distribution (Vermunt &
Magidson, 2005).
Hypothesis 2 could not be analyzed as planned. Due to low frequencies in the 4-class
model from the LCA, there was insufficient power to conduct regression analyses even between
the two largest classes; therefore, descriptive and bivariate results are reported. Bivariate
analyses were conducted with three out of the four classes identified (Low-Blunt, Low-Bong,
and Mod-Poly classes), while the High-Poly class could not be included in these bivariate
analyses due to low frequencies. Comparisons between LCA classes were performed with the
following variables: gender, race/ethnicity, school grades, past 30-day tobacco/nicotine use
(collapsed across products), past 30-day use of individual tobacco/nicotine product types
(cigarettes, traditional cigars, pipes, little cigars, electronic cigarettes, chew, dip/snuff, and
hookah), lifetime alcohol use, BSSS score, cannabis dependence score, cannabis harm
perceptions, and average cannabis occasions per month. Cases with “Other” as gender were
excluded from Hypothesis 2 analyses, as well as cases with “Not sure” for school grades (n = 4),
resulting in a sample size of 204 for Hypothesis 2.
For Hypothesis 3, equivalence of groups randomized to each cannabis policy condition
(three levels; legal-policy, medical-policy, illegal-policy) was assessed using bivariate tests
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examining demographic items (gender, age, race/ethnicity), level of school attainment, year in
college, school grades, current and previous state of residence, lifetime alcohol use, medicinal
cannabis prescription, past-30 day tobacco use, lifetime cannabis use, past year cannabis use,
past 30-day cannabis use, and baseline intentions to use cannabis. Items that differed
significantly between cannabis policy conditions were included as covariates in the one-way
ANCOVA models. Prior to conducting planned ANCOVAs, normality was assessed visually for
each post-randomization outcome: cannabis attitudes, injunctive norms, perceived behavioral
control, self-efficacy, and post-randomization intentions to use cannabis. Perceived behavioral
control exhibited an extremely strong rightward skew (skewness = -1.87 and kurtotis value =
4.45) due to a large proportion of responses at the highest value; this variable was transformed
using the reflect and inverse formula (new variable = 1/(K – old variable) where K = largest
possible value +1). Following any required transformations, between-subjects one-way
ANCOVA were conducted for each post-randomization outcome. If the overall ANCOVA F-test
was significant, post-hoc comparisons were completed using the Bonferroni correction to
identify mean differences on dependent variables between each cannabis policy condition.
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Results
Total Sample Descriptives
Table 5 displays demographics, cannabis use characteristics, and other substance use
characteristics for the total sample (N = 457). Over two-thirds of the sample was female, and the
average age of the sample was 20 years old. The sample was racially/ethnically diverse with
42.5% identifying as “White or European-American,” 17.7% identifying as “Black, AfroCaribbean, or African American,” 14.4% identifying as “Asian-American,” 11.6% identifying as
“Hispanic/Latino,” and 13.8% identifying as Multiracial or “Other.” Over two-thirds had used
any tobacco product in the past month, and 91.7% of the sample had drank alcohol in their
lifetime. Most of the sample had used cannabis in their lifetime (72.9%), 61.5% had used
cannabis in the past year, and 45.5% had used cannabis in the past 30 days. Of past 30-day
cannabis users, the most frequently used methods of cannabis administration were bong and
blunt (over half of the sample) with bowl/pipe and joint used slightly less frequently (between
40-50%; see Table 6). The least frequently used methods were edible and vaporizer/rig. Among
past 30-day users, bong was used on the most occasions and days per month, followed by blunt
and bowl/pipe.
Descriptive analyses were conducted for the demographics of participants who were
excluded from the analyses (n = 86), and bivariate analyses were conducted to compare
demographics between included and excluded participants. A third of participants did not report
age (31.4%); however, of those that did report age, the mean age was 20 years old. There was
insufficient evidence to suggest there was a significant age difference between included and
excluded participants. Similar patterns were reported for race/ethnicity; a third of participants did
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Table 5. Total Sample Descriptives

Characteristic
Gender
Male
Female
Other
Age in years
Race
White or European-American
Black, Afro-Caribbean, or African American
Asian-American
Hispanic/Latino
Multiracial/Other
Level of school attainment
High school or GED
Some college/no degree
Associate's or Bachelor's degree
Missing
Year in college
1st
2nd
3rd
4th
5th or more
Missing
School grades
Mostly A's
Mostly B's
Mostly C's, D's, or F's
Not sure
Missing
Current state of residence
Maryland
New Jersey
Virginia
Past state of residence
Virginia
Other state
Lifetime alcohol use
Past 30-day tobacco use
Medicinal cannabis prescription
Lifetime cannabis use
Past year cannabis use
Past 30-day cannabis use

Total N = 457
n (%) or M (SD)
147 (32.2%)
307 (67.2%)
3 (0.7%)
20.04 (2.88)
194 (42.5%)
81 (17.7%)
66 (14.4%)
53 (11.6%)
63 (13.8%)
210 (46.0%)
188 (41.1%)
57 (12.5%)
2 (0.4%)
206 (45.1%)
95 (20.8%)
81 (17.7%)
44 (9.6%)
20 (4.4%)
11 (2.4%)
125 (27.4%)
246 (53.8%)
77 (16.8%)
6 (1.3%)
3 (0.7%)
2 (0.4%)
1 (0.2%)
454 (99.3%)
405 (88.6%)
52 (11.4%)
419 (91.7%)
306 (67.0%)
0 (0%)
333 (72.9%)
281 (61.5%)
208 (45.5%)
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Table 6. Characteristics of Past 30-day Users by Cannabis Administration Method
Proportion of past
Average cannabis
Average cannabis
30-day cannabis
use occasions in
use days in past 30
users*
past 30
(%)
M (SD)
M (SD)
Joint
40.0%
3.1 (8.7)
2.4 (5.8)
Blunt
54.8%
4.4 (9.8)
3.9 (7.3)
Bowl/pipe
50.0%
3.8 (8.6)
3.6 (7.1)
Bong
54.8%
6.8 (15.0)
4.9 (8.8)
Edible
27.4%
0.5 (1.3)
0.5 (1.2)
Vaporizer/rig
19.2%
2.5 (11.9)
1.5 (5.4)
Note: Asterisks (*) indicate these groups are non-exclusive. Mean (SD) occasions and
days reported were specific to that method among past 30-day users.
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Table 7. Latent Class Model Comparisons
Number of classes
1
2
3
4
5
6
7
8
9
10

AIC
2051.163
1915.844
1894.96
1888.8
1887.246
1886.813
1889.126
1892.753
1896.935
1913.41

BIC
Class.Err.
L²
Npar
p
2084.538
0 421.6165
10 3.00E-18
1985.932
0.0212 264.2972
21 0.00017
2001.761
0.0179 221.4135
32
0.012
2032.314
0.1111 193.2536
43
0.065
2067.473
0.1533 169.6994
54
0.18
2103.753
0.0703 147.2663
65
0.39
2142.779
0.0811 127.5796
76
0.59
2183.119
0.0792 109.2069
87
0.77
2224.014
0.0602 91.3888
98
0.9
2277.201
0.0718 85.8632 109
0.82

Bootstrapped 3
1894.96 2001.761
0.0179 221.4135
32
0.012
Bootstrapped 4
1888.8 2032.314
0.1111 193.2536
43
0.065
Note: Bolded text indicates final model selected. Class. Err. indicates classification
error. Npar indicates number of parameters.
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not report their race/ethnicity (33.7%). Of those that did report their race/ethnicity, 15.8%
identified as “White or European-American,” 21.1% identified as “Black, Afro-Caribbean, or
African American,” 21.1% identified as “Asian-American,” 19.3% identified as
“Hispanic/Latino,” and 22.8% identified as Multiracial or “Other.” Chi-square analyses indicated
there were significant differences of race/ethnicity between included and excluded participants (p
< 0.005). Among participants who were excluded, 36% did not report their gender, and among
those who did report gender, 47.3% identified as male and 52.7% identified as female. There was
insufficient evidence to suggest there was a significant difference between the distribution of
gender of included and excluded participants.
Hypothesis 1 Results – LCA
Based on the BIC, the fit of the model improved from a 1-class model (2084.54) to the 2class model (1985.93); however, the model fit weakened for the proceeding models (2001.76 –
2277.20; See Table 7). Based on the AIC, the fit of the model improved from the 1-class model
(2051.16) to the 6-class model (1886.81), but weakened following the 6-class model to the 10class model (1886.81 – 1913.41). Classification errors remained below 15% for all models. The
1-class model had the highest L2 statistic (421.62) with gradually decreasing values with each
subsequent model (264.30 – 85.86). The 1-class model had the lowest number of parameters
(10), and the number of parameters increased with each subsequent model (21 – 109). Based on
the AIC, BIC, classification error, L2 statistics, number of parameters, and the p-value, the 4model class was chosen as the best fit. The 4-class model with and without bootstrapping had an
AIC of 1888.8, a BIC of 2032.3, a classification error of 11.1%, an L2 statistic of 193.3, 43
parameters, and p = 0.065.
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Table 8 displays the conditional probabilities and the assigned labels of the selected 4class model. Conditional probabilities ranging from 0-0.30 are considered low, 0.31-0.60 are
considered moderate, and 0.61-0.99 are considered high (personal communication with A.
Nasim; Nasim et al., 2012; Nasim et al., 2016). The Low-Blunt class was the largest class,
representing 60.1% of past 30-day cannabis users (n = 125). The Low-Blunt class was
characterized by a high probability of using blunts 1-10 times per month and high probabilities
of using joints, bowls/pipes, bongs, edibles, and vaporizers/rigs 0 times per month. The LowBong class contained 23.6% of past 30-day cannabis users (n = 49). The Low-Bong class had a
high probability of using bongs 1-10 times per month. The Low-Bong class had high
probabilities of using joints, blunts, edibles, and vaporizers/rigs 0 times per month and had a
moderate probability of using bowls/pipes 0 times per month and 1-10 times per month. The
Mod-Poly class consisted of 12.5% of past 30-day cannabis users (n = 26). The Mod-Poly class
had high probabilities of using joints, blunts, and bowls/pipes 1-10 times per month and of using
bongs 10 or more times per month. The Mod-Poly class also had high probabilities of using
edibles and vaporizers/rigs in the past month. The High-Poly class was the smallest class, which
accounted for 3.8% of the sample (n = 8). The High-Poly class was characterized by high
probabilities of using joints, blunts, bowls/pipes, and bongs 10 or more times per month and of
using edibles and vaporizers in the past month.
Hypothesis 2 Results – Descriptives
There were significant differences between the three largest LCA classes (i.e., LowBlunt, Low-Bong, and Mod-Poly; n = 196) and the distribution of gender (p = 0.05; See Table
9). The Low-Blunt class consisted of 73.8% females, while the Low-Bong and Mod-Poly classes
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Table 8. Latent Class Analysis Probabilities

Reported cluster size from Latent Gold
Actual calculated cluster size
n = 208
Past 30-day occasions of joint use
0 times
1-10 times
10+ times
Past 30-day occasions of blunt use
0 times
1-10 times
10+ times
Past 30-day occasions of bowl/pipe use
0 times
1-10 times
10+ times
Past 30-day occasions of bong use
0 times
1-10 times
10+ times
Past 30-day use of edibles
No
Yes
Past 30-day vaporizer/rig use
No
Yes

LowBlunt
59.6%
60.1%
n = 125

LowBong
23.3%
23.6%
n = 49

ModPoly
13.1%
12.5%
n = 26

HighPoly
4.0%
3.8%
n=8

0.64
0.31
0.04

0.89
0.02
0.09

0.07
0.93
0.00

0.02
0.01
0.97

0.46
0.54
0.00

0.76
0.06
0.18

0.00
0.81
0.19

0.01
0.01
0.97

0.63
0.33
0.04

0.40
0.46
0.14

0.20
0.69
0.11

0.14
0.14
0.73

0.68
0.32
0.00

0.19
0.63
0.18

0.00
0.37
0.62

0.02
0.01
0.97

0.78
0.22

0.93
0.07

0.31
0.69

0.14
0.86

0.91
0.09

0.94
0.06

0.18
0.82

0.63
0.37
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Table 9. Hypothesis 2 Descriptives and Bivariate Associations with Latent Class Analysis Class
Status

Characteristics

Low-Blunt
n = 122
n (%) or
M (SD)

Low-Bong
n = 48
n (%) or
M (SD)

Mod-Poly
n = 26
n (%) or
M (SD)

p

Gender

High-Poly
n=8
n (%) or
M (SD)

0.045

Male

32 (26.2%)

20 (41.7%)

12 (46.2%)

3 (37.5%)

Female

90 (73.8%)

28 (58.3%)

14 (53.8%)

5 (62.5%)

White

45 (36.9%)

27 (56.3%)

16 (61.5%)

4 (50.0%)

Black

31 (25.4%)

7 (14.6%)

2 (7.7%)

1 (12.5%)

Asian

8 (6.6%)

5 (10.4%)

3 (11.5%)

--

Race/Ethnicity

0.021

Hispanic/Latino

20 (16.4%)

1 (2.1%)

4 (15.4%)

1 (12.5%)

Multiracial/Other

18 (14.8%)

8 (16.7%)

1 (3.8%)

2 (25.0%)

School Grades

0.218

Mostly A's

21 (17.2%)

14 (29.2%)

6 (23.1%)

--

Mostly B's

80 (65.6%)

24 (50.0%)

18 (69.2%)

3 (37.5%)

Mostly C's, D's, or F's

21 (17.2%)

10 (20.8%)

2 (7.7%)

5 (62.5%)

26 (54.2%)

19 (73.1%)

~

0.039

6 (75.0%)

30 (24.6%)

18 (37.5%)

11 (42.3%)

0.088

4 (50.0%)

Past 30-day traditional cigars

5 (4.1%)

1 (2.1%)

2 (7.7%)

N/A

--

Past 30-day pipe

2 (1.6%)

--

--

N/A

--

20 (16.4%)

8 (16.7%)

9 (34.6%)

0.088

5 (62.5%)

6 (4.9%)*^

8 (16.7%)^

7 (26.9%)*

0.001

2 (25.0%)

Past 30-day chew

1 (0.8%)

1 (2.1%)

--

N/A

--

Past 30-day dip/snuff

1 (0.8%)

2 (4.2%)

3 (11.5%)

N/A

--

13 (10.7%)

5 (10.4%)

6 (23.1%)

0.194

--

122 (100.0%)

47 (97.9%)

26 (100.0%)

N/A

8 (100.0%)

Sensation seeking (BSSS)

25.8 (5.5)

25.9 (5.2)

28.4 (4.9)

0.072

26.8 (6.2)

Cannabis dependence score

5.8 (1.7)*

6.5 (2.1)

7.4 (2.7)*

0.008

7.1 (2.6)

Past 30-day tobacco use
Past 30-day cigarettes

Past 30-day little cigars
Past 30-day electronic
cigarettes

Past 30-day hookah
Lifetime alcohol use

56 (45.9%)

~

Cannabis harm perceptions
2.7 (1.4)
2.6 (1.2)
2.7 (1.2)
0.937
1.9 (0.7)
Average days of cannabis use per
month
6.4 (7.7)*^
12.2 (11.3)^~
25.2 (7.7)*~
<0.001
28.4 (3.5)
Note: Bivariate tests (chi-square, ANOVA) and associated p-values compared data among the Low-Blunt, Low-Bong,
and Mod-Poly classes; High-Poly was excluded due to low frequencies. Welch test was used due to violation of
homogeneity of variance for cannabis dependence and average days of cannabis use per month. N/A indicates that at
least 30% of expected cell counts were less than 5; therefore, bivariate statistical results were unreliable. Asterisks (*)
indicate a significant difference at the 0.05 level between Low-Blunt and Mod-Poly. Carets (^) indicate a significant
difference at the 0.05 level between Low-Blunt and Low-Bong. Tildes (~) indicate a significant difference at the 0.05
level between Low-Bong and Mod-Poly. For past 30-day tobacco use, no participants reported dissolvable tobacco,
snus, or nicotine replacement therapy use.
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consisted 58.3% and 53.8% females, respectively. There were significant differences between
LCA class and the distribution of race/ethnicity (p = 0.02). The Low-Blunt class had a higher
proportion of individuals of Hispanic/Latino and Black race/ethnicity than the Low-Bong and
Mod-Poly classes. The Low-Bong class and Mod-Poly class primarily consisted of individuals of
White race/ethnicity (56.3% and 61.5%, respectively). There were also significant differences
between the three LCA classes and the distribution of past 30-day tobacco use (p = 0.04).
Approximately 73% of the Mod-Poly class were past 30-day tobacco users compared to 46% of
the Low-Blunt class and 54% of the Low-Bong class. There were significant differences between
the LCA classes and endorsement of past 30-day use of electronic cigarettes (p = 0.001). In the
Mod-Poly class, 26.9% had used an electronic cigarette in the past 30 days compared to only
16.7% in the Low-Bong class and 4.9% in the Low-Blunt class. Due to violations in
homogeneity of variance, the adjusted F test (i.e., Welch statistic) indicated that there was a
significant difference between the three LCA classes and cannabis dependence, F(2, 54) = 5.327,
p = 0.01. There were statistically significant differences between average cannabis dependence
scores for the Mod-Poly class and the Low-Blunt class, such that that Mod-Poly class had a
higher cannabis dependence score. There were significant differences between the three LCA
classes and average monthly cannabis use in days, F(2, 59) = 63.747, p < 0.001. There were
statistically significant differences between the Low-Blunt and Low-Bong classes, the LowBong class and the Mod-Poly class, as well as, the Low-Blunt and Mod-Poly classes.
Hypothesis 3 Results – Cannabis Policy Conditions
Results for bivariate and ANCOVA analyses are presented in Tables 10 and 11. For
bivariate associations between the cannabis policy conditions and the potential covariates, results
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Table 10. Hypothesis 3 Descriptives and Bivariate Associations by Cannabis Policy Condition
Legal-policy
n = 149
n (%) or M (SD)

Medical-policy
n = 150
n (%) or M (SD)

Illegal-policy
n = 147
n (%) or M (SD)

Characteristic
p
Gender
0.872
Male
46 (30.9%)
50 (33.3%)
49 (33.3%)
Female
103 (69.1%)
100 (66.7%)
98 (66.7%)
Age in years
20.2 (3.1)
20.0 (2.5)
19.9 (3.1)
0.578
Race
0.187
White
68 (45.6%)
71 (47.3%)
50 (34.0%)
Black
31 (20.8%)
22 (14.7%)
25 (17.0%)
Asian
19 (12.8%)
22 (14.7%)
23 (15.6%)
Hispanic/Latino
16 (10.7%)
15 (10.0%)
22 (15.0%)
Multiracial/Other
15 (10.1%)
20 (13.3%)
27 (18.4%)
Level of school attainment
0.171
High school or GED
60 (40.5%)
72 (48.3%)
73 (49.7%)
Some college/no degree
62 (41.9%)
62 (41.6%)
60 (40.8%)
Associate's or Bachelor's
26 (17.6%)
15 (10.1%)
14 (9.5%)
degree
Year in college
0.002
1st
54 (36.7%)
66 (45.2%)
82 (56.9%)
2nd
35 (23.8%)
36 (24.7%)
23 (16.0%)
3rd
40 (27.2%)
20 (13.7%)
19 (13.2%)
4th
14 (9.5%)
14 (9.6%)
16 (11.1%)
5th or more
4 (2.7%)
10 (6.8%)
4 (2.8%)
School grades
0.024
Mostly A's
34 (22.8%)
48 (32.0%)
42 (28.6%)
Mostly B's
95 (63.8%)
68 (45.3%)
83 (56.5%)
Mostly C's, D's, or F's
20 (13.4%)
34 (22.7%)
22 (15.0%)
Current state of residence
N/A
Maryland
2 (1.3%)
--New Jersey
--1 (0.7%)
Virginia
147 (98.7%)
150 (100.0%)
146 (99.3%)
Past state of residence
0.313
Virginia
129 (86.6%)
138 (92.0%)
130 (88.4%)
Other state
20 (13.4%)
12 (8.0%)
17 (11.6%)
Lifetime alcohol use
137 (91.9%)
136 (90.7%)
135 (91.8%)
0.908
Medicinal cannabis prescription
0 (0%)
0 (0%)
0 (0%)
-Past 30-day tobacco use
44 (29.5%)
54 (36.0%)
51 (34.7%)
0.456
Lifetime cannabis use
102 (68.5%)
117 (78.0%)
107 (72.8%)
0.176
Past year cannabis use
84 (56.4%)
97 (64.7%)
94 (63.9%)
0.476
Past 30-day cannabis use
67 (45.0%)
66 (44.0%)
71 (48.3%)
0.186
Baseline intentions to use
8.5 (6.6)
9.8 (6.7)
10.5 (7.3)
0.030
cannabis
Note: Welch test was used due to violation of homogeneity of variance for baseline intentions to use
cannabis; N/A indicates that at least 30% of expected cell counts were less than 5; therefore, bivariate
statistical results were unreliable.
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Table 11. Analysis of Covariance Results for Experimental Outcomes
Overall
Sample
M (SE)
15.1 (0.4)
7.9 (0.2)
18.5 (0.2)
0.6 (0.2)
19.8 (0.3)

Legal-policy

Medical-policy

Illegal-policy

Outcome measure
M (SE)
M (SE)
M (SE)
p
Attitudes about cannabis
16.2 (0.6)*
16.4 (0.5)^
12.6 (0.6)*^
<0.001
Injunctive norms
8.2 (0.3)
8.2 (0.3)
7.4 (0.3)
0.045
Perceived behavioral control (PBC)
18.8 (0.3)
18.6 (0.3)
18.0 (0.3)
0.170
Log-transformed PBC
0.7 (0.04)
0.6 (0.03)
0.6 (0.04)
0.443
Self-efficacy to use cannabis
20.6 (0.6)*
20.4 (0.5)^
18.3 (0.6)*^
0.005
Post-randomization intentions to use
10.2 (0.2)
11.0 (0.3)*
10.4 (0.3)^
9.3 (0.3)*^
<0.001
cannabis
Note: M (SE) reported above include covariates appearing in the model evaluated at the following values: school year = 2.04, past 30day cannabis use = 0.4577, and baseline intentions to use cannabis = 9.59. Attitude scores ranged from 7 to 28. Higher mean attitude
scores indicated more favorable attitudes about cannabis. Injunctive norm scores ranged from 7 to 21. Higher mean injunctive norms
scores indicated a higher agreement that social supporters think they should use cannabis. PBC scores ranged from 7 to 21. Higher
mean scores for PBC indicated stronger beliefs that a person is able to use cannabis. Self-efficacy scores ranged from 7 to 28. Higher
mean self-efficacy scores indicated a higher self-confidence in the ability to use cannabis. Post-randomization intentions scores ranged
from 7 to 21. Higher mean post-randomization intentions scores indicated higher intentions to use cannabis. Asterisks (*) indicate a
significant difference at the 0.05 level between illegal condition and legal condition. Carets (^) indicate a significant different at the
0.05 level between medical condition and illegal condition.
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indicated that there were significant differences between the cannabis policy conditions and year
in college (p = 0.002) and school grades (p = 0.024) as well as baseline intentions to use
cannabis (p = 0.030; See Table 10). These three variables were included as covariates in the
subsequent ANCOVAs, as well as past 30-day cannabis use due to this behavior’s salience in the
analysis outcomes.
Among the planned five ANCOVAs conducted controlling for year in school, school
grades, past 30-day cannabis use, and baseline intentions to use cannabis, four outcomes had a
significant effect of cannabis policy condition (see Table 11). There was a significant effect of
cannabis policy condition on attitudes about cannabis, F(2, 429) = 15.590, p < 0.001. Post-hoc
comparisons using the Bonferroni correction revealed the legal-policy and medical-policy
conditions resulted in significantly more positive attitudes about cannabis relative to the illegalpolicy condition (ps < 0.05). However, the cannabis attitudes in the legal-policy condition did
not significantly differ from the medical-policy condition.
There was a significant effect of cannabis policy condition on injunctive norms for
cannabis use, F(2, 429) = 3.115, p = 0.045. Post-hoc comparisons revealed there were no
differences between cannabis policy conditions although descriptively the illegal-policy
condition had the lowest injunctive norms relative to the medical-policy condition and the legalpolicy condition.
There was insufficient evidence to suggest there was a significant effect of cannabis
policy condition on perceived behavioral control, F(2, 429) = 1.777, p = 0.170.
There was a significant effect of cannabis policy condition on self-efficacy, F(2, 429) =
5.409, p = 0.005. Post-hoc comparisons using the Bonferroni correction revealed the legal-policy
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and the medical-policy conditions resulted in significantly higher self-efficacy scores compared
to the illegal-policy condition (ps < 0.05). However, the mean self-efficacy scores in the legalpolicy condition did not significantly differ from the medical-policy condition.
There was a significant effect of cannabis policy condition on post-randomization
intentions to use cannabis, F(2, 429) = 10.802, p < 0.001. Post-hoc comparisons using the
Bonferroni correction revealed the legal-policy and medical-policy conditions resulted in
significantly higher post-randomization intentions to use cannabis score relative to the illegalpolicy condition (ps < 0.05). However, the post-randomization intentions to use cannabis score in
the legal-policy condition did not significantly differ from the mean score in the medical-policy
condition.
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Discussion
The purpose of the current study was 1) to assess patterns of cannabis consumption
among young adults using LCA, 2) to determine if these patterns were associated with
differential demographics and other factors, as well as 3) to test if hypothetical cannabis policy
environments influenced attitudes about cannabis, injunctive norms, perceived behavioral
control, self-efficacy, and intentions to use cannabis among young adults. Approximately 450
students completed the study and 45% were current (past 30-day) cannabis users. Four latent
classes of cannabis users based on frequency of past 30-day administration methods of cannabis
use were identified. Three of the largest classes differed by gender, race/ethnicity, past 30-day
tobacco use, past 30-day electronic cigarette use, cannabis dependence, and average days of
cannabis use per month. These data reveal unique groups of cannabis users that can be targeted
more effectively for prevention and intervention efforts. As this study was conducted in an
illegal cannabis policy environment, it would be valuable to identify if these same sub-groups of
cannabis users exist in a legal cannabis policy environment and/or medicinal cannabis policy
environment. In Hypothesis 3, results indicated that legal and medicinal cannabis policy
conditions increased attitudes about cannabis, injunctive norms, self-efficacy, and intentions to
use cannabis relative to the illegal cannabis policy condition. These data reveal that a simple
hypothetical policy manipulation can change intentions to use cannabis. Based on the TPB, these
behavioral intentions may lead to changes in behaviors. It is plausible that real changes in
cannabis policies can alter cannabis use; however, more research is needed in real-life situations
in order to explore this association.
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Hypothesis 1
For Hypothesis 1, we expected to find a large class of young adults who used
combustion-based methods of cannabis (e.g., joints, blunts, bongs). However, in the current
study, four latent classes were identified (Low-Blunt, Low-Bong, Mod-Poly, High-Poly), where
several specific methods of administration were highlighted, as well as varying frequencies of
use. Previous literature has often compared cannabis users to non-users, implying that cannabis
users are a homogenous group (Lipperman-Kreda, Paschall, Robert, & Morrison, 2017;
Pedersen, Hummer, Rinker, Traylor, & Neighbors, 2016); however, data from the current study
revealed that there are unique sub-groups among cannabis users. The Low-Blunt and the LowBong classes comprised over three-quarters of the sample (84%), and both were characterized by
high probabilities of using either blunts or bongs between 1-10 times per month. On the other
hand, the Mod-Poly and High-Poly classes were smaller in size (4-13%) and were characterized
by high probabilities of using all methods of cannabis administration and for some, at higher
frequencies (10+ times per month). The Mod-Poly class was characterized by high probabilities
of using edibles and rigs/vaporizers, while the High-Poly class was characterized by a high
probability of using edibles but a low probability of using rigs/vaporizers.
Although several studies have conducted LCAs on cannabis users (Baggio et al., 2014;
Krauss, Rajbhandari, Sowles, Spitznagel, & Cavazos-Rehg, 2017; Pearson et al., 2017), none
have used this type of analysis with the inclusion of a range of cannabis methods of
administration as well as use frequencies of these methods. One longitudinal Swiss study
conducted between 2010 and 2011 identified sub-groups of male adult cannabis users based on
methods of administration; however, the study only included frequencies of joints, cannabis
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“mixed with food,” and water pipes in their LCA (Baggio et al., 2014). Results indicated that
joint users comprised the largest latent class, followed by users who reported low frequencies of
joints, water pipes, and cannabis “mixed with food” and users who reported high frequencies of
joints, water pipes, and cannabis “mixed with food” (Baggio et al., 2014). Contrasting from the
Baggio et al. (2014) article, the inclusion of more methods of cannabis administration revealed a
Low-Blunt class and a Low-Bong class, but similarly to the Baggio et al. (2014) study, the
smallest class in both studies was the high frequency use of multiple methods of cannabis
administration (i.e., High-Poly class).
Compared to studies that measured the use of different cannabis methods of
administration, several similarities were apparent. The use of blunts and bongs were most
frequently reported among past 30-day cannabis users in the present sample (54.8% and 54.8%,
respectively), which corroborates findings from past literature among an adult population
recruited online between 2010-2012 (Hughes et al., 2014). However, our results differed from a
study conducted in 2014 among a representative nationwide sample of adults which reported
bowl/pipe use as the most frequently endorsed method of administration (50%), followed by
joints (49%), bongs (22%), and vaporizers (8%; Schauer et al., 2016). These discrepancies
between studies could exist due to the changes in cannabis policies since 2010, which could have
affected nationwide patterns of use and/or due to the changes in cannabis policies by state. The
current study was conducted in a Mid-Atlantic state, whereas the aforementioned studies were
conducted with nationwide samples (Hughes et al., 2014; Schauer et al., 2016). Also consistent
with past literature, use of multiple methods was common in two latent classes (i.e., Mod-Poly
and High-Poly; Hughes et al, 2014; Schauer et al., 2016).
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Hypothesis 2
For Hypothesis 2, we expected to identify differences between latent classes on
demographics, harm perceptions, and risk-taking behaviors. However, the LCA revealed four
latent classes which limited our analyses to simpler techniques than were proposed. Therefore,
bivariate statistics were conducted to describe the data. We found significant differences between
three latent classes (i.e., Low-Blunt, Low-Bong, Mod-Poly) by gender, race/ethnicity, past 30day tobacco use, past 30-day electronic cigarette use, cannabis dependence, and average days of
cannabis use per month.
Low-Blunt users were primarily female (73.8%) and were more racial/ethnical diverse
with a high proportion of people who identified as Black (25.4%) compared to the other classes
(Low-Bong 14.6%; Mod-Poly 7.1%). Almost half of Low-Blunt users reported past 30-day
tobacco use, and Low-Blunt users reported a significantly lower amount of past 30-day
electronic cigarette use compared to the Low-Bong and Mod-Poly classes. Cannabis dependence
was significantly lower in the Low-Blunt class compared to the Mod-Poly class, and on average,
the Low-Blunt class reported the lowest number of days of past month cannabis use.
The Low-Bong class consisted of a higher proportion of females than males (58.3% vs.
41.7%), and these individuals primarily identified as White (56.3%). Over half of the Low-Bong
users reported past 30-day tobacco use and significantly more Low-Bong users reported
electronic cigarette use compared to the Low-Blunt class. The Low-Bong class reported a
significantly higher average number of days of cannabis use per month compared to the LowBlunt class; however, the Low-Bong class reported a significantly lower average number of days
of cannabis use per month compared to the Mod-Poly class.
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The Mod-Poly class also consisted of more females than males (53.8% vs. 46.2%), and
they primarily identified as White (61.5%). The Mod-Poly class had the highest proportion of
past 30-day tobacco users compared to the Low-Blunt and Low-Bong classes with a significant
difference between the Low-Blunt and Mod-Poly classes. The Mod-Poly class also reported the
highest proportion of past 30-day electronic cigarette use which was significantly higher than the
Low-Blunt class and the Mod-Poly class. Cannabis dependence was highest in the Mod-Poly
class, which was significantly higher than the Low-Blunt class. Finally, the average days of
cannabis use per month was significantly higher in the Mod-Poly class compared to both LowBlunt and Low-Bong classes.
The High-Poly class consisted of more females than males (62.5% vs. 37.5%) and was
ethnically/racially diverse with half of the sample identifying as White and a quarter of the
sample identifying as Multiracial/Other. The High-Poly class earned mostly C, D, or F grades in
school. The High-Poly class endorsed the highest proportion of past 30-day tobacco use
compared to the other three classes, as well as the highest proportion of past 30-day cigarette use
and little cigar use. Cannabis dependence in the High-Poly class was similar to cannabis
dependence scores in the Mod-Poly class. Interestingly, the High-Poly class reported the lowest
cannabis harm perceptions compared to the other three classes. Finally, the High-Poly class, on
average, used cannabis almost every day in the past 30 days.
There were no significant differences between the Low-Blunt, Low-Bong, and Mod-Poly
classes on school grades, past 30-day cigarette, traditional cigars, tobacco pipes, little cigars,
chew, dip/snuff, or hookah, lifetime alcohol use, sensation seeking, or cannabis harm
perceptions.
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Due to the limited literature on cannabis methods of administration, many of the current
findings are unique to the current study. However, past literature has explored some correlates of
specific methods of cannabis administration which can allow for some comparisons to current
study result. Past literature has indicated that blunt users are more likely to identify as female and
Black, non-Hispanics, which is consistent with the Low-Blunt class (A. Cohn et al., 2016; J. R.
Hughes et al., 2014; Timberlake, 2009). More frequent cannabis use has been correlated with
vaporizer use, which is consistent with the Mod-Poly class (D. C. Lee et al., 2016). Importantly,
previous literature on correlates of cannabis administration methods has not included frequencies
of administration method use. Further research is needed to replicate the findings in the current
study in order to inform intervention efforts for these sub-groups of cannabis users.
The results indicate that there are unique groups of cannabis users which can be targeted
for specific intervention. Evidence-based cannabis interventions most often consist of cognitive
behavioral therapy, contingency management, motivational enhancement therapy, or a
combination of these interventions (NIDA, 2012). Cognitive behavioral therapy involves the
development of coping skills in order to manage and/or abstain from substance use (NIDA,
2012). Contingency management interventions consist of providing a monetary or voucher
incentive (which acts as a positive reinforcement) to refrain from substance use (NIDA, 2012).
Finally, motivational enhancement therapy is a form of counseling in which internal motivation
is fostered in the client in order to promote abstinence (NIDA, 2012). Although these cannabis
interventions are widely used and often result in abstinence, previous research on cannabis
interventions generalize cannabis users as a homogenous group (ignoring the various methods of
cannabis administration; e.g., Budney, Moore, Rocha, & Higgins, 2006; Carroll et al., 2006;
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Marijuana Treatment Project Research, 2004; Schuster et al., 2016). Based on the findings from
the current study, it may be useful to apply these interventions to specific groups of cannabis
users. Regarding the current study, the largest latent class, the Low-Blunt class, could benefit
from cognitive behavioral therapy that specifically targets blunt use and highlights its risks
including the harms of acute exposure to tobacco products (i.e., in the blunt wrap).
Although cannabis interventions often target cannabis users without the consideration of
the various methods of cannabis administration, cannabis interventions also focus on and are
sought by dependent cannabis users. The Mod-Poly and High-Poly classes had the highest levels
of cannabis dependence and frequency of use, suggesting potentially more severe substance use
disorder symptomology and that more intensive treatment strategies, such as a combination of
cognitive behavioral therapy and contingency management, would benefit these individuals.
Contingency management interventions have often been used with adolescent cannabis users;
however, contingency management interventions may be also useful for young adult cannabis
users who may not have a desire to abstain from cannabis use. Previous literature conducted in
2009 on young adults’ interest in receiving cannabis treatment indicated that less frequent
cannabis use was associated with a decreased interest to participate in cannabis treatment
(Buckner, Ecker, & Cohen, 2010). Due to the low frequency of cannabis use in the Low-Blunt
and Low-Bong classes in the current study, these users may benefit from motivational
enhancement therapy, in order to increase the desire to participate in cannabis treatment and
abstain from cannabis use. Importantly, all classes were likely to report concurrent tobacco use
(46-75%) consistent with other literature regarding the co-occurrence of substance use behavior
(Agrawal & Lynskey, 2009; Schauer, Berg, Kegler, Donovan, & Windle, 2015, 2016). Effective
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interventions may be best served to incorporate features of tobacco and cannabis use cessation; it
may be most advantageous to target both substances at the same time (Becker, Haug, Kraemer,
& Schaub, 2015; Becker, Haug, Sullivan, & Schaub, 2014; Becker et al., 2013). These results
also indicate a need for clinical practitioners and researchers to avoid treating past month
cannabis users as one homogenous group during assessment. Asking about the individual’s
unique patterns of cannabis use (i.e., their methods of cannabis administration) lends a better
understanding to the individual’s specific harm potential.
The latent classes identified in the current study were characterized by unique
combinations of cannabis methods of use which may be related to harmfulness. Available
research has indicated that there may be differential health effects associated with the various
methods of cannabis administration. For example, combustion-based methods of cannabis
administration (e.g., blunts and joints) are associated with increased coughing, exposure to
carbon monoxide, and the development of lung disease and cancer (Martinasek et al., 2016;
Yayan & Rasche, 2016). In the current study, the two largest classes, Low-Blunt and Low-Bong,
were characterized by methods of cannabis administration that rely on combustion. These two
classes may experience similar combustion-related negative health effects. The Mod-Poly and
High-Poly classes were characterized by use of all methods of administration including
combusted and non-combusted. These classes may be exposed to combustion-based negative
health effects, as well as negative health effects from using other methods of administration. For
example, both the Mod-Poly and High-Poly classes resulted in high probabilities of using
edibles, and the use of edibles is associated with mouth irritation (Cho et al., 2005). It is
unknown whether the use of multiple methods of cannabis administration is associated with a
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greater number of negative health effects. More research is needed to explore the potential
additive negative health effects of multiple methods of cannabis administration.
Hypothesis 3
The purpose of Hypothesis 3 was to test if hypothetical cannabis policy environments
influenced attitudes about cannabis, injunctive norms, perceived behavioral control, selfefficacy, and intentions to use cannabis among young adults. We expected the legal-policy
condition would elicit the highest intentions to use cannabis, followed by the medical-policy
condition and the illegal-policy condition. We expected self-reported attitudes, injunctive norms,
perceived behavioral control, and self-efficacy to be highest in the legal-policy condition and
lowest in the illegal-policy condition.
Consistent with our hypotheses, attitudes about cannabis were significantly different
across cannabis policy environments when controlling for year in school, school grades, past 30day cannabis use, and baseline intentions to use cannabis. The illegal drug condition was
associated with significantly less favorable attitudes about cannabis compared to the legal-policy
condition and the medical-policy condition. The medical-policy condition was associated with
the most favorable attitudes about cannabis, but the medical-policy condition did not
significantly differ from the legal-policy condition. There were significant differences between
cannabis policy environments and injunctive norms. The legal- and medical-policy conditions
were associated with higher injunctive norms compared to the illegal-policy condition. More
simply stated, those in the legal- and medical-policy conditions more often agreed that their
social supporters (i.e., family members and important others) think they should use cannabis.
Inconsistent with our hypotheses, perceived behavioral control did not differ across cannabis
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policy environments. Self-efficacy to use cannabis differed significantly across cannabis policy
environments. The legal-policy and the medical-policy conditions were associated with
significantly higher self-efficacy to use cannabis scores compared to the illegal-policy condition.
The illegal-policy condition was associated with significantly less self-efficacy to use cannabis
compared to the medical-policy condition and the legal-policy condition. The legal-policy
condition had the highest self-efficacy to use cannabis scores, but the legal-policy condition did
not significantly differ from the medical-policy condition. Finally, the post-randomization
intentions to use cannabis differed across cannabis policy conditions. Similar to previous results,
the legal-policy and medical-policy conditions were associated with significantly higher
intentions to use cannabis compared to the illegal-policy condition, with the legal-policy
condition resulting in the highest intentions to use cannabis.
These results indicate that using an experimental design with a behavior change theory
rationale results in differences in intentions to use cannabis across hypothetical cannabis policy
conditions. Intentions to use is the most closely-related antecedent to actual behavior in the TPB.
Therefore, these data could point to potential changes in cannabis use patterns due to cannabis
policy changes, such that more relaxed cannabis policies elicit higher intentions to use cannabis
among young adults. Although these results were found in the current study, longitudinal data
collected in California from 1995 to 1999 (prior to and following the legalization of cannabis for
medicinal purposes) indicated that actual cannabis use behaviors did not increase among all age
groups as a function of legalizing medicinal cannabis in 1996 (Khatapoush & Hallfors, 2004).
More recent research using combined longitudinal data from MTF (from 1991-2014), the
National Longitudinal Surveys of Youth (from 1997-2005), the YRBS (from 1991-2011) and the
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NSDUH (from 2002-2013) indicated that adolescents’ use of cannabis did not significantly
increase after medical cannabis laws were enacted; however, in the same study, according to the
NSDUH (from 2004-2013) and the National Institute on Alcohol Abuse and Alcoholism surveys
(from 1991-2012), cannabis use increased among adults after legalization of cannabis for
medicinal use (Carliner, Brown, Sarvet, & Hasin, 2017). This discrepancy provides motivation
for more longitudinal research across many states to determine the real-life, long-term effects of
cannabis policy changes across different ages.
Results from Hypothesis 3 also indicated that attitudes about cannabis were significantly
most favorable in the medical-policy and legal-policy conditions compared to the illegal-policy
condition. This finding is unsurprising, given that favorable cannabis attitudes tend to coincide
with the legalization of cannabis for recreational and medicinal purposes. This finding is
consistent with a study that used data from the NSDUH (from 2003-2011) on the differences
between adults’ cannabis attitudes in Colorado (during which the state allowed the use of
cannabis only for medicinal purposes) compared to 34 states that had illegal cannabis policies at
the time (Schuermeyer et al., 2014). Results indicated that adults in Colorado had significantly
higher approval rates for cannabis use compared to adults in states with illegal cannabis laws
(Schuermeyer et al., 2014). Importantly, among Colorado and states with illegal cannabis laws,
approval rates for cannabis increased from 2003 to 2011 (Schuermeyer et al., 2014). Taken
together, evidence suggests that less restrictive cannabis policy is associated with more favorable
attitudes toward cannabis. Further research should continue to monitor cannabis attitudes in
states with legalized cannabis for recreational and/or medicinal purposes, as well as, monitor
nationwide trends on cannabis attitudes.
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Limitations
There were several limitations to the current study. One common to surveys among
specific college-based samples relates to generalizability. It is possible that results found here
may be specific to the geographic region and time due to differences in environmental influences
as well as relevant policies. Social desirability bias also may have influenced self-reports of
marijuana use (Welte & Russell, 1993); although the data collection techniques (data were never
linked to participant names) may have reduced this effect. Previous studies have also relied on
self-report for other substance behaviors that are restricted (i.e., alcohol) and shown them to be
valid and reliable (Del Boca & Darkes, 2003). However, recall errors may have also occurred in
the current study. Future research should utilize multiple methods of self-report (e.g., timeline
follow back) in order to increase reliability (Hjorthoj, Hjorthoj, & Nordentoft, 2012). Another
limitation to the current study is the use of a hypothetical policy environment to invoke changes
in behavioral intentions. Although the results of the study showed a successful policy
manipulation, conducting this study across US states with varying policy environments would
have been stronger in order to better generalize to other populations. Regarding methods, the
survey did not ask about health status of the participant themselves or of their family members.
Differences in these variables could have affected the injunctive norms which asked about the
perception of family members’ opinions about cannabis use. For example, if a family member is
sick and uses cannabis medicinally, injunctive norms of the participant could be elevated
compared to participants without this influence. Although unknown prior to the study, a larger
sample size would have allowed for sufficient power to conduct regression analyses for
Hypothesis 2.
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Conclusions and Future Directions
The current study identified four unique sub-groups of cannabis users and differential
demographics, tobacco, and cannabis use behaviors between these groups. Using the results from
this study, these sub-groups of cannabis users can be more effectively targeted for intervention
efforts. These results also provide support for the notion that cannabis users have heterogeneous
use patterns which may be associated with differential harms. Results from the current study also
indicated that a recreationally and medicinally legalized cannabis policy environment increased
attitudes, injunctive norms, self-efficacy, and intentions to use cannabis. Using the TPB as
context for these findings, cannabis use behaviors could increase due to the legalization of
cannabis for recreational or medicinal purposes. Therefore, studying attitudes about cannabis,
self-efficacy to use cannabis, and intention to use cannabis in real-life situations in a variety of
states, pre- and post-policy changes would be beneficial to fully understand the effects of policy
changes.
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Appendix A
Below is an example of the legal-policy condition prompt which was shown to the
participant immediately after randomization to condition.
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Appendix B

Below is an example of the legal-policy condition prompt which was shown to the
participant at the top of each measure after randomization to condition.
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